#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Simultaneous fMRI-EEG-DTI recording of MMN in patients with schizophrenia Functional magnetic resonance imaging (fMRI), electroencephalogram (EEG), and diffusion tensor imaging (DTI) recording have complementary spatiotemporal resolution limitations but can be powerful methods when used together to enable both functional and anatomical modeling, with each neuroimaging procedure used to maximum advantage.
1-1	0-12	Simultaneous	_
1-2	13-25	fMRI-EEG-DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
1-3	26-35	recording	_
1-4	36-38	of	_
1-5	39-42	MMN	http://maven.renci.org/NeuroBridge/neurobridge#Thing
1-6	43-45	in	_
1-7	46-54	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-8	55-59	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-9	60-73	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-10	74-84	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-11	85-93	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-12	94-103	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-13	104-111	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-14	112-113	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-15	114-118	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-16	119-120	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-17	121-122	,	_
1-18	123-143	electroencephalogram	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
1-19	144-145	(	_
1-20	146-149	EEG	_
1-21	150-151	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
1-22	152-153	,	_
1-23	154-157	and	_
1-24	158-167	diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
1-25	168-174	tensor	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
1-26	175-182	imaging	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
1-27	183-184	(	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
1-28	185-188	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
1-29	189-190	)	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
1-30	191-200	recording	_
1-31	201-205	have	_
1-32	206-219	complementary	_
1-33	220-234	spatiotemporal	_
1-34	235-245	resolution	_
1-35	246-257	limitations	_
1-36	258-261	but	_
1-37	262-265	can	_
1-38	266-268	be	_
1-39	269-277	powerful	_
1-40	278-285	methods	_
1-41	286-290	when	_
1-42	291-295	used	_
1-43	296-304	together	_
1-44	305-307	to	_
1-45	308-314	enable	_
1-46	315-319	both	_
1-47	320-330	functional	_
1-48	331-334	and	_
1-49	335-345	anatomical	_
1-50	346-354	modeling	_
1-51	355-356	,	_
1-52	357-361	with	_
1-53	362-366	each	_
1-54	367-379	neuroimaging	_
1-55	380-389	procedure	_
1-56	390-394	used	_
1-57	395-397	to	_
1-58	398-405	maximum	_
1-59	406-415	advantage	_
1-60	416-417	.	_

Text=We recorded EEGs during event-related fMRI followed by DTI in 15 healthy volunteers and 12 patients with schizophrenia using an omission mismatch negativity (MMN) paradigm.
2-1	418-420	We	_
2-2	421-429	recorded	_
2-3	430-434	EEGs	http://maven.renci.org/NeuroBridge/neurobridge#Thing
2-4	435-441	during	_
2-5	442-455	event-related	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
2-6	456-460	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
2-7	461-469	followed	_
2-8	470-472	by	_
2-9	473-476	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
2-10	477-479	in	_
2-11	480-482	15	_
2-12	483-490	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-13	491-501	volunteers	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-14	502-505	and	_
2-15	506-508	12	_
2-16	509-517	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-17	518-522	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-18	523-536	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-19	537-542	using	_
2-20	543-545	an	_
2-21	546-554	omission	_
2-22	555-563	mismatch	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
2-23	564-574	negativity	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
2-24	575-576	(	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
2-25	577-580	MMN	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
2-26	581-582	)	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
2-27	583-591	paradigm	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
2-28	592-593	.	_

Text=Blood oxygenation level-dependent (BOLD) signal changes were calculated in a region of interest (ROI) analysis, and fractional anisotropy (FA) in the white matter fibers related to each area was compared between groups using tract-specific analysis.
3-1	594-599	Blood	_
3-2	600-611	oxygenation	_
3-3	612-627	level-dependent	_
3-4	628-629	(	_
3-5	630-634	BOLD	_
3-6	635-636	)	_
3-7	637-643	signal	_
3-8	644-651	changes	_
3-9	652-656	were	_
3-10	657-667	calculated	_
3-11	668-670	in	_
3-12	671-672	a	_
3-13	673-679	region	_
3-14	680-682	of	_
3-15	683-691	interest	_
3-16	692-693	(	_
3-17	694-697	ROI	_
3-18	698-699	)	_
3-19	700-708	analysis	_
3-20	709-710	,	_
3-21	711-714	and	_
3-22	715-725	fractional	_
3-23	726-736	anisotropy	_
3-24	737-738	(	_
3-25	739-741	FA	_
3-26	742-743	)	_
3-27	744-746	in	_
3-28	747-750	the	_
3-29	751-756	white	_
3-30	757-763	matter	_
3-31	764-770	fibers	_
3-32	771-778	related	_
3-33	779-781	to	_
3-34	782-786	each	_
3-35	787-791	area	_
3-36	792-795	was	_
3-37	796-804	compared	_
3-38	805-812	between	_
3-39	813-819	groups	_
3-40	820-825	using	_
3-41	826-840	tract-specific	_
3-42	841-849	analysis	_
3-43	850-851	.	_

Text=Patients with schizophrenia had reduced BOLD activity in the left middle temporal gyrus, and BOLD activity in the right insula and right parahippocampal gyrus significantly correlated with positive symptoms on the Positive and Negative Syndrome Scale (PANSS) and hostility subscores.
4-1	852-860	Patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-2	861-865	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-3	866-879	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-4	880-883	had	_
4-5	884-891	reduced	_
4-6	892-896	BOLD	_
4-7	897-905	activity	_
4-8	906-908	in	_
4-9	909-912	the	_
4-10	913-917	left	_
4-11	918-924	middle	_
4-12	925-933	temporal	_
4-13	934-939	gyrus	_
4-14	940-941	,	_
4-15	942-945	and	_
4-16	946-950	BOLD	_
4-17	951-959	activity	_
4-18	960-962	in	_
4-19	963-966	the	_
4-20	967-972	right	_
4-21	973-979	insula	_
4-22	980-983	and	_
4-23	984-989	right	_
4-24	990-1005	parahippocampal	_
4-25	1006-1011	gyrus	_
4-26	1012-1025	significantly	_
4-27	1026-1036	correlated	_
4-28	1037-1041	with	_
4-29	1042-1050	positive	_
4-30	1051-1059	symptoms	_
4-31	1060-1062	on	_
4-32	1063-1066	the	_
4-33	1067-1075	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-34	1076-1079	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-35	1080-1088	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-36	1089-1097	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-37	1098-1103	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-38	1104-1105	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-39	1106-1111	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-40	1112-1113	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
4-41	1114-1117	and	_
4-42	1118-1127	hostility	_
4-43	1128-1137	subscores	_
4-44	1138-1139	.	_

Text=BOLD activation of Heschl ’ s gyri also correlated with the limbic system, including the insula.
5-1	1140-1144	BOLD	_
5-2	1145-1155	activation	_
5-3	1156-1158	of	_
5-4	1159-1165	Heschl	_
5-5	1166-1167	’	_
5-6	1168-1169	s	_
5-7	1170-1174	gyri	_
5-8	1175-1179	also	_
5-9	1180-1190	correlated	_
5-10	1191-1195	with	_
5-11	1196-1199	the	_
5-12	1200-1206	limbic	_
5-13	1207-1213	system	_
5-14	1214-1215	,	_
5-15	1216-1225	including	_
5-16	1226-1229	the	_
5-17	1230-1236	insula	_
5-18	1237-1238	.	_

Text=FA values in the left anterior cingulate cortex (ACC) significantly correlated with changes in the BOLD signal in the right superior temporal gyrus (STG), and FA values in the right ACC significantly correlated with PANSS scores.
6-1	1239-1241	FA	_
6-2	1242-1248	values	_
6-3	1249-1251	in	_
6-4	1252-1255	the	_
6-5	1256-1260	left	_
6-6	1261-1269	anterior	_
6-7	1270-1279	cingulate	_
6-8	1280-1286	cortex	_
6-9	1287-1288	(	_
6-10	1289-1292	ACC	_
6-11	1293-1294	)	_
6-12	1295-1308	significantly	_
6-13	1309-1319	correlated	_
6-14	1320-1324	with	_
6-15	1325-1332	changes	_
6-16	1333-1335	in	_
6-17	1336-1339	the	_
6-18	1340-1344	BOLD	_
6-19	1345-1351	signal	_
6-20	1352-1354	in	_
6-21	1355-1358	the	_
6-22	1359-1364	right	_
6-23	1365-1373	superior	_
6-24	1374-1382	temporal	_
6-25	1383-1388	gyrus	_
6-26	1389-1390	(	_
6-27	1391-1394	STG	_
6-28	1395-1396	)	_
6-29	1397-1398	,	_
6-30	1399-1402	and	_
6-31	1403-1405	FA	_
6-32	1406-1412	values	_
6-33	1413-1415	in	_
6-34	1416-1419	the	_
6-35	1420-1425	right	_
6-36	1426-1429	ACC	_
6-37	1430-1443	significantly	_
6-38	1444-1454	correlated	_
6-39	1455-1459	with	_
6-40	1460-1465	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
6-41	1466-1472	scores	_
6-42	1473-1474	.	_

Text=This is the first study to examine MMN using simultaneous fMRI, EEG, and DTI recording in patients with schizophrenia to investigate the potential implications of abnormalities in the ACC and limbic system, including the insula and parahippocampal gyrus, as well as the STG.
7-1	1475-1479	This	_
7-2	1480-1482	is	_
7-3	1483-1486	the	_
7-4	1487-1492	first	_
7-5	1493-1498	study	_
7-6	1499-1501	to	_
7-7	1502-1509	examine	_
7-8	1510-1513	MMN	_
7-9	1514-1519	using	_
7-10	1520-1532	simultaneous	_
7-11	1533-1537	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
7-12	1538-1539	,	_
7-13	1540-1543	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
7-14	1544-1545	,	_
7-15	1546-1549	and	_
7-16	1550-1553	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
7-17	1554-1563	recording	_
7-18	1564-1566	in	_
7-19	1567-1575	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-20	1576-1580	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-21	1581-1594	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-22	1595-1597	to	_
7-23	1598-1609	investigate	_
7-24	1610-1613	the	_
7-25	1614-1623	potential	_
7-26	1624-1636	implications	_
7-27	1637-1639	of	_
7-28	1640-1653	abnormalities	_
7-29	1654-1656	in	_
7-30	1657-1660	the	_
7-31	1661-1664	ACC	_
7-32	1665-1668	and	_
7-33	1669-1675	limbic	_
7-34	1676-1682	system	_
7-35	1683-1684	,	_
7-36	1685-1694	including	_
7-37	1695-1698	the	_
7-38	1699-1705	insula	_
7-39	1706-1709	and	_
7-40	1710-1725	parahippocampal	_
7-41	1726-1731	gyrus	_
7-42	1732-1733	,	_
7-43	1734-1736	as	_
7-44	1737-1741	well	_
7-45	1742-1744	as	_
7-46	1745-1748	the	_
7-47	1749-1752	STG	_
7-48	1753-1754	.	_

Text=Structural changes in the ACC during schizophrenia may represent part of the neural basis for the observed MMN deficits.
8-1	1755-1765	Structural	_
8-2	1766-1773	changes	_
8-3	1774-1776	in	_
8-4	1777-1780	the	_
8-5	1781-1784	ACC	_
8-6	1785-1791	during	_
8-7	1792-1805	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-8	1806-1809	may	_
8-9	1810-1819	represent	_
8-10	1820-1824	part	_
8-11	1825-1827	of	_
8-12	1828-1831	the	_
8-13	1832-1838	neural	_
8-14	1839-1844	basis	_
8-15	1845-1848	for	_
8-16	1849-1852	the	_
8-17	1853-1861	observed	_
8-18	1862-1865	MMN	_
8-19	1866-1874	deficits	_
8-20	1875-1876	.	_

Text=The deficits seen in the feedback/feedforward connections between the prefrontal cortex and STG modulated by the ACC and insula may specifically contribute to impaired MMN generation and clinical manifestations.
9-1	1877-1880	The	_
9-2	1881-1889	deficits	_
9-3	1890-1894	seen	_
9-4	1895-1897	in	_
9-5	1898-1901	the	_
9-6	1902-1922	feedback/feedforward	_
9-7	1923-1934	connections	_
9-8	1935-1942	between	_
9-9	1943-1946	the	_
9-10	1947-1957	prefrontal	_
9-11	1958-1964	cortex	_
9-12	1965-1968	and	_
9-13	1969-1972	STG	_
9-14	1973-1982	modulated	_
9-15	1983-1985	by	_
9-16	1986-1989	the	_
9-17	1990-1993	ACC	_
9-18	1994-1997	and	_
9-19	1998-2004	insula	_
9-20	2005-2008	may	_
9-21	2009-2021	specifically	_
9-22	2022-2032	contribute	_
9-23	2033-2035	to	_
9-24	2036-2044	impaired	_
9-25	2045-2048	MMN	_
9-26	2049-2059	generation	_
9-27	2060-2063	and	_
9-28	2064-2072	clinical	_
9-29	2073-2087	manifestations	_
9-30	2088-2089	.	_

Text=Methods Ethical statement This study was approved by the Juntendo University Koshigaya Hospital Ethics Committee and Juntendo University Shizuoka Hospital Ethics Committee.
10-1	2090-2097	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
10-2	2098-2105	Ethical	_
10-3	2106-2115	statement	_
10-4	2116-2120	This	_
10-5	2121-2126	study	_
10-6	2127-2130	was	_
10-7	2131-2139	approved	_
10-8	2140-2142	by	_
10-9	2143-2146	the	_
10-10	2147-2155	Juntendo	_
10-11	2156-2166	University	_
10-12	2167-2176	Koshigaya	_
10-13	2177-2185	Hospital	_
10-14	2186-2192	Ethics	_
10-15	2193-2202	Committee	_
10-16	2203-2206	and	_
10-17	2207-2215	Juntendo	_
10-18	2216-2226	University	_
10-19	2227-2235	Shizuoka	_
10-20	2236-2244	Hospital	_
10-21	2245-2251	Ethics	_
10-22	2252-2261	Committee	_
10-23	2262-2263	.	_

Text=Subjects Twelve patients with schizophrenia (10 men and 2 women, mean age 36.8 ± 6.0 years, all right-handed except for one left-handed patient) and 15 healthy controls (13 men and 2 women, mean age 28.4 ± 9.6 years, all right-handed except for one left-handed subject) were included in the study.
11-1	2264-2272	Subjects	_
11-2	2273-2279	Twelve	_
11-3	2280-2288	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-4	2289-2293	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-5	2294-2307	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-6	2308-2309	(	_
11-7	2310-2312	10	_
11-8	2313-2316	men	_
11-9	2317-2320	and	_
11-10	2321-2322	2	_
11-11	2323-2328	women	_
11-12	2329-2330	,	_
11-13	2331-2335	mean	_
11-14	2336-2339	age	_
11-15	2340-2344	36.8	_
11-16	2345-2346	±	_
11-17	2347-2350	6.0	_
11-18	2351-2356	years	_
11-19	2357-2358	,	_
11-20	2359-2362	all	_
11-21	2363-2375	right-handed	_
11-22	2376-2382	except	_
11-23	2383-2386	for	_
11-24	2387-2390	one	_
11-25	2391-2402	left-handed	_
11-26	2403-2410	patient	_
11-27	2411-2412	)	_
11-28	2413-2416	and	_
11-29	2417-2419	15	_
11-30	2420-2427	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-31	2428-2436	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-32	2437-2438	(	_
11-33	2439-2441	13	_
11-34	2442-2445	men	_
11-35	2446-2449	and	_
11-36	2450-2451	2	_
11-37	2452-2457	women	_
11-38	2458-2459	,	_
11-39	2460-2464	mean	_
11-40	2465-2468	age	_
11-41	2469-2473	28.4	_
11-42	2474-2475	±	_
11-43	2476-2479	9.6	_
11-44	2480-2485	years	_
11-45	2486-2487	,	_
11-46	2488-2491	all	_
11-47	2492-2504	right-handed	_
11-48	2505-2511	except	_
11-49	2512-2515	for	_
11-50	2516-2519	one	_
11-51	2520-2531	left-handed	_
11-52	2532-2539	subject	_
11-53	2540-2541	)	_
11-54	2542-2546	were	_
11-55	2547-2555	included	_
11-56	2556-2558	in	_
11-57	2559-2562	the	_
11-58	2563-2568	study	_
11-59	2569-2570	.	_

Text=The groups were not age-matched (F [1,25] = 5.3, p = 0.11).
12-1	2571-2574	The	_
12-2	2575-2581	groups	_
12-3	2582-2586	were	_
12-4	2587-2590	not	_
12-5	2591-2602	age-matched	_
12-6	2603-2604	(	_
12-7	2605-2606	F	_
12-8	2607-2608	[	_
12-9	2609-2613	1,25	_
12-10	2614-2615	]	_
12-11	2616-2617	=	_
12-12	2618-2621	5.3	_
12-13	2622-2623	,	_
12-14	2624-2625	p	_
12-15	2626-2627	=	_
12-16	2628-2632	0.11	_
12-17	2633-2634	)	_
12-18	2635-2636	.	_

Text=Attempts were made to match the groups for years of education, but this proved to be difficult because patients with schizophrenia are more likely to require hospitalization and the early age of onset, which can interfere with schooling.
13-1	2637-2645	Attempts	_
13-2	2646-2650	were	_
13-3	2651-2655	made	_
13-4	2656-2658	to	_
13-5	2659-2664	match	_
13-6	2665-2668	the	_
13-7	2669-2675	groups	_
13-8	2676-2679	for	_
13-9	2680-2685	years	_
13-10	2686-2688	of	_
13-11	2689-2698	education	_
13-12	2699-2700	,	_
13-13	2701-2704	but	_
13-14	2705-2709	this	_
13-15	2710-2716	proved	_
13-16	2717-2719	to	_
13-17	2720-2722	be	_
13-18	2723-2732	difficult	_
13-19	2733-2740	because	_
13-20	2741-2749	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-21	2750-2754	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-22	2755-2768	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-23	2769-2772	are	_
13-24	2773-2777	more	_
13-25	2778-2784	likely	_
13-26	2785-2787	to	_
13-27	2788-2795	require	_
13-28	2796-2811	hospitalization	_
13-29	2812-2815	and	_
13-30	2816-2819	the	_
13-31	2820-2825	early	_
13-32	2826-2829	age	_
13-33	2830-2832	of	_
13-34	2833-2838	onset	_
13-35	2839-2840	,	_
13-36	2841-2846	which	_
13-37	2847-2850	can	_
13-38	2851-2860	interfere	_
13-39	2861-2865	with	_
13-40	2866-2875	schooling	_
13-41	2876-2877	.	_

Text=Therefore, controls had significantly more (F [1,25] = 0.130, p <0.001) years of education (17.3 ± 1.9) than patients (13.3 ± 2.0).
14-1	2878-2887	Therefore	_
14-2	2888-2889	,	_
14-3	2890-2898	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-4	2899-2902	had	_
14-5	2903-2916	significantly	_
14-6	2917-2921	more	_
14-7	2922-2923	(	_
14-8	2924-2925	F	_
14-9	2926-2927	[	_
14-10	2928-2932	1,25	_
14-11	2933-2934	]	_
14-12	2935-2936	=	_
14-13	2937-2942	0.130	_
14-14	2943-2944	,	_
14-15	2945-2946	p	_
14-16	2947-2948	<	_
14-17	2949-2954	0.001	_
14-18	2955-2956	)	_
14-19	2957-2962	years	_
14-20	2963-2965	of	_
14-21	2966-2975	education	_
14-22	2976-2977	(	_
14-23	2978-2982	17.3	_
14-24	2983-2984	±	_
14-25	2985-2988	1.9	_
14-26	2989-2990	)	_
14-27	2991-2995	than	_
14-28	2996-3004	patients	_
14-29	3005-3006	(	_
14-30	3007-3011	13.3	_
14-31	3012-3013	±	_
14-32	3014-3017	2.0	_
14-33	3018-3019	)	_
14-34	3020-3021	.	_

Text=The statistical procedures were adjusted for age and education.
15-1	3022-3025	The	_
15-2	3026-3037	statistical	_
15-3	3038-3048	procedures	_
15-4	3049-3053	were	_
15-5	3054-3062	adjusted	_
15-6	3063-3066	for	_
15-7	3067-3070	age	_
15-8	3071-3074	and	_
15-9	3075-3084	education	_
15-10	3085-3086	.	_

Text=Patients were recruited from among the outpatients at Juntendo University Koshigaya Hospital in Saitama and Juntendo University Shizuoka Hospital in Shizuoka, Japan, and healthy controls were recruited from the staff of the same hospitals.
16-1	3087-3095	Patients	_
16-2	3096-3100	were	_
16-3	3101-3110	recruited	_
16-4	3111-3115	from	_
16-5	3116-3121	among	_
16-6	3122-3125	the	_
16-7	3126-3137	outpatients	_
16-8	3138-3140	at	_
16-9	3141-3149	Juntendo	_
16-10	3150-3160	University	_
16-11	3161-3170	Koshigaya	_
16-12	3171-3179	Hospital	_
16-13	3180-3182	in	_
16-14	3183-3190	Saitama	_
16-15	3191-3194	and	_
16-16	3195-3203	Juntendo	_
16-17	3204-3214	University	_
16-18	3215-3223	Shizuoka	_
16-19	3224-3232	Hospital	_
16-20	3233-3235	in	_
16-21	3236-3244	Shizuoka	_
16-22	3245-3246	,	_
16-23	3247-3252	Japan	_
16-24	3253-3254	,	_
16-25	3255-3258	and	_
16-26	3259-3266	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-27	3267-3275	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-28	3276-3280	were	_
16-29	3281-3290	recruited	_
16-30	3291-3295	from	_
16-31	3296-3299	the	_
16-32	3300-3305	staff	_
16-33	3306-3308	of	_
16-34	3309-3312	the	_
16-35	3313-3317	same	_
16-36	3318-3327	hospitals	_
16-37	3328-3329	.	_

Text=All controls were healthy and native to Japan.
17-1	3330-3333	All	_
17-2	3334-3342	controls	_
17-3	3343-3347	were	_
17-4	3348-3355	healthy	_
17-5	3356-3359	and	_
17-6	3360-3366	native	_
17-7	3367-3369	to	_
17-8	3370-3375	Japan	_
17-9	3376-3377	.	_

Text=The mean disease duration in the patient group was 14.3 ± 5.7 years, and the mean drug dose used for treatment (risperidone equivalent) was 10.5 ± 6.2 mg (Table 1).
18-1	3378-3381	The	_
18-2	3382-3386	mean	_
18-3	3387-3394	disease	_
18-4	3395-3403	duration	_
18-5	3404-3406	in	_
18-6	3407-3410	the	_
18-7	3411-3418	patient	_
18-8	3419-3424	group	_
18-9	3425-3428	was	_
18-10	3429-3433	14.3	_
18-11	3434-3435	±	_
18-12	3436-3439	5.7	_
18-13	3440-3445	years	_
18-14	3446-3447	,	_
18-15	3448-3451	and	_
18-16	3452-3455	the	_
18-17	3456-3460	mean	_
18-18	3461-3465	drug	_
18-19	3466-3470	dose	_
18-20	3471-3475	used	_
18-21	3476-3479	for	_
18-22	3480-3489	treatment	_
18-23	3490-3491	(	_
18-24	3492-3503	risperidone	_
18-25	3504-3514	equivalent	_
18-26	3515-3516	)	_
18-27	3517-3520	was	_
18-28	3521-3525	10.5	_
18-29	3526-3527	±	_
18-30	3528-3531	6.2	_
18-31	3532-3534	mg	_
18-32	3535-3536	(	_
18-33	3537-3542	Table	_
18-34	3543-3544	1	_
18-35	3545-3546	)	_
18-36	3547-3548	.	_

Text=All patients were determined to be in good physical health based on medical history, physical examination, and laboratory measures.
19-1	3549-3552	All	_
19-2	3553-3561	patients	_
19-3	3562-3566	were	_
19-4	3567-3577	determined	_
19-5	3578-3580	to	_
19-6	3581-3583	be	_
19-7	3584-3586	in	_
19-8	3587-3591	good	_
19-9	3592-3600	physical	_
19-10	3601-3607	health	_
19-11	3608-3613	based	_
19-12	3614-3616	on	_
19-13	3617-3624	medical	_
19-14	3625-3632	history	_
19-15	3633-3634	,	_
19-16	3635-3643	physical	_
19-17	3644-3655	examination	_
19-18	3656-3657	,	_
19-19	3658-3661	and	_
19-20	3662-3672	laboratory	_
19-21	3673-3681	measures	_
19-22	3682-3683	.	_

Text=None of the subjects had a history of electroconvulsive shock treatment, alcohol or other drug abuse (DSM-5 criteria), addiction, or a neurological illness affecting the central nervous system, and all subjects reported having normal visual acuity.
20-1	3684-3688	None	_
20-2	3689-3691	of	_
20-3	3692-3695	the	_
20-4	3696-3704	subjects	_
20-5	3705-3708	had	_
20-6	3709-3710	a	_
20-7	3711-3718	history	_
20-8	3719-3721	of	_
20-9	3722-3739	electroconvulsive	_
20-10	3740-3745	shock	_
20-11	3746-3755	treatment	_
20-12	3756-3757	,	_
20-13	3758-3765	alcohol	_
20-14	3766-3768	or	_
20-15	3769-3774	other	_
20-16	3775-3779	drug	_
20-17	3780-3785	abuse	_
20-18	3786-3787	(	_
20-19	3788-3793	DSM-5	_
20-20	3794-3802	criteria	_
20-21	3803-3804	)	_
20-22	3805-3806	,	_
20-23	3807-3816	addiction	_
20-24	3817-3818	,	_
20-25	3819-3821	or	_
20-26	3822-3823	a	_
20-27	3824-3836	neurological	_
20-28	3837-3844	illness	_
20-29	3845-3854	affecting	_
20-30	3855-3858	the	_
20-31	3859-3866	central	_
20-32	3867-3874	nervous	_
20-33	3875-3881	system	_
20-34	3882-3883	,	_
20-35	3884-3887	and	_
20-36	3888-3891	all	_
20-37	3892-3900	subjects	_
20-38	3901-3909	reported	_
20-39	3910-3916	having	_
20-40	3917-3923	normal	_
20-41	3924-3930	visual	_
20-42	3931-3937	acuity	_
20-43	3938-3939	.	_

Text=The DSM-5 diagnosis and Positive and Negative Syndrome Scale (PANSS) score were determined for each patient using a structured psychiatric interview and by reviewing the patients ’ medical charts.
21-1	3940-3943	The	_
21-2	3944-3949	DSM-5	_
21-3	3950-3959	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#DiseaseDiagnosis
21-4	3960-3963	and	_
21-5	3964-3972	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-6	3973-3976	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-7	3977-3985	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-8	3986-3994	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-9	3995-4000	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-10	4001-4002	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-11	4003-4008	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-12	4009-4010	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
21-13	4011-4016	score	_
21-14	4017-4021	were	_
21-15	4022-4032	determined	_
21-16	4033-4036	for	_
21-17	4037-4041	each	_
21-18	4042-4049	patient	_
21-19	4050-4055	using	_
21-20	4056-4057	a	_
21-21	4058-4068	structured	_
21-22	4069-4080	psychiatric	_
21-23	4081-4090	interview	_
21-24	4091-4094	and	_
21-25	4095-4097	by	_
21-26	4098-4107	reviewing	_
21-27	4108-4111	the	_
21-28	4112-4120	patients	_
21-29	4121-4122	’	_
21-30	4123-4130	medical	_
21-31	4131-4137	charts	_
21-32	4138-4139	.	_

Text=The PANSS is a semi-structured interview with a 7-point scale to rate 30 symptoms common in schizophrenia and other mental disorders.
22-1	4140-4143	The	_
22-2	4144-4149	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-3	4150-4152	is	_
22-4	4153-4154	a	_
22-5	4155-4170	semi-structured	_
22-6	4171-4180	interview	_
22-7	4181-4185	with	_
22-8	4186-4187	a	_
22-9	4188-4195	7-point	_
22-10	4196-4201	scale	_
22-11	4202-4204	to	_
22-12	4205-4209	rate	_
22-13	4210-4212	30	_
22-14	4213-4221	symptoms	_
22-15	4222-4228	common	_
22-16	4229-4231	in	_
22-17	4232-4245	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
22-18	4246-4249	and	_
22-19	4250-4255	other	_
22-20	4256-4262	mental	_
22-21	4263-4272	disorders	_
22-22	4273-4274	.	_

Text=The mean PANSS scores were 15.4±6.9 (positive scales), 22.8±9.2 (negative scales), 36.8±10.3 (general psychopathology scales), and 74.9±22.9 (total score).
23-1	4275-4278	The	_
23-2	4279-4283	mean	_
23-3	4284-4289	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
23-4	4290-4296	scores	_
23-5	4297-4301	were	_
23-6	4302-4310	15.4±6.9	_
23-7	4311-4312	(	_
23-8	4313-4321	positive	_
23-9	4322-4328	scales	_
23-10	4329-4330	)	_
23-11	4331-4332	,	_
23-12	4333-4341	22.8±9.2	_
23-13	4342-4343	(	_
23-14	4344-4352	negative	_
23-15	4353-4359	scales	_
23-16	4360-4361	)	_
23-17	4362-4363	,	_
23-18	4364-4373	36.8±10.3	_
23-19	4374-4375	(	_
23-20	4376-4383	general	_
23-21	4384-4399	psychopathology	_
23-22	4400-4406	scales	_
23-23	4407-4408	)	_
23-24	4409-4410	,	_
23-25	4411-4414	and	_
23-26	4415-4424	74.9±22.9	_
23-27	4425-4426	(	_
23-28	4427-4432	total	_
23-29	4433-4438	score	_
23-30	4439-4440	)	_
23-31	4441-4442	.	_

Text=All participants were informed of the objectives and methods of the study and given written informed consent before the study began.
24-1	4443-4446	All	_
24-2	4447-4459	participants	_
24-3	4460-4464	were	_
24-4	4465-4473	informed	_
24-5	4474-4476	of	_
24-6	4477-4480	the	_
24-7	4481-4491	objectives	_
24-8	4492-4495	and	_
24-9	4496-4503	methods	_
24-10	4504-4506	of	_
24-11	4507-4510	the	_
24-12	4511-4516	study	_
24-13	4517-4520	and	_
24-14	4521-4526	given	_
24-15	4527-4534	written	_
24-16	4535-4543	informed	_
24-17	4544-4551	consent	_
24-18	4552-4558	before	_
24-19	4559-4562	the	_
24-20	4563-4568	study	_
24-21	4569-4574	began	_
24-22	4575-4576	.	_

Text=The treating psychiatrists evaluated the capability of the patients to give informed consent and confirmed that they understood the voluntariness of their participation.
25-1	4577-4580	The	_
25-2	4581-4589	treating	_
25-3	4590-4603	psychiatrists	_
25-4	4604-4613	evaluated	_
25-5	4614-4617	the	_
25-6	4618-4628	capability	_
25-7	4629-4631	of	_
25-8	4632-4635	the	_
25-9	4636-4644	patients	_
25-10	4645-4647	to	_
25-11	4648-4652	give	_
25-12	4653-4661	informed	_
25-13	4662-4669	consent	_
25-14	4670-4673	and	_
25-15	4674-4683	confirmed	_
25-16	4684-4688	that	_
25-17	4689-4693	they	_
25-18	4694-4704	understood	_
25-19	4705-4708	the	_
25-20	4709-4722	voluntariness	_
25-21	4723-4725	of	_
25-22	4726-4731	their	_
25-23	4732-4745	participation	_
25-24	4746-4747	.	_

Text=Any participants who lacked adequate understanding of the study were excluded.
26-1	4748-4751	Any	_
26-2	4752-4764	participants	_
26-3	4765-4768	who	_
26-4	4769-4775	lacked	_
26-5	4776-4784	adequate	_
26-6	4785-4798	understanding	_
26-7	4799-4801	of	_
26-8	4802-4805	the	_
26-9	4806-4811	study	_
26-10	4812-4816	were	_
26-11	4817-4825	excluded	_
26-12	4826-4827	.	_

Text=Five-component model of the PANSS As described previously, clinical manifestations were evaluated by the PANSS, which is classified into five components according to the five-component model: negative (passive withdrawal, emotional withdrawal, blunted affects, lack of spontaneity, poor rapport, disturbance of volition, preoccupation, motor retardation), positive (delusions, unusual thoughts, somatic concern, grandiosity, suspiciousness, hallucinations), cognitive (difficulty in abstract thinking, stereotyped thinking, cognitive disorganization, lack of judgment and insight, poor attention, tension, mannerisms and posturing), emotional discomfort (depression, anxiety, guilt, active social avoidance), and hostility (excitement, hostility, impulse control, uncooperativeness).
27-1	4828-4842	Five-component	_
27-2	4843-4848	model	_
27-3	4849-4851	of	_
27-4	4852-4855	the	_
27-5	4856-4861	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
27-6	4862-4864	As	_
27-7	4865-4874	described	_
27-8	4875-4885	previously	_
27-9	4886-4887	,	_
27-10	4888-4896	clinical	_
27-11	4897-4911	manifestations	_
27-12	4912-4916	were	_
27-13	4917-4926	evaluated	_
27-14	4927-4929	by	_
27-15	4930-4933	the	_
27-16	4934-4939	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
27-17	4940-4941	,	_
27-18	4942-4947	which	_
27-19	4948-4950	is	_
27-20	4951-4961	classified	_
27-21	4962-4966	into	_
27-22	4967-4971	five	_
27-23	4972-4982	components	_
27-24	4983-4992	according	_
27-25	4993-4995	to	_
27-26	4996-4999	the	_
27-27	5000-5014	five-component	_
27-28	5015-5020	model	_
27-29	5021-5022	:	_
27-30	5023-5031	negative	_
27-31	5032-5033	(	_
27-32	5034-5041	passive	_
27-33	5042-5052	withdrawal	_
27-34	5053-5054	,	_
27-35	5055-5064	emotional	_
27-36	5065-5075	withdrawal	_
27-37	5076-5077	,	_
27-38	5078-5085	blunted	_
27-39	5086-5093	affects	_
27-40	5094-5095	,	_
27-41	5096-5100	lack	_
27-42	5101-5103	of	_
27-43	5104-5115	spontaneity	_
27-44	5116-5117	,	_
27-45	5118-5122	poor	_
27-46	5123-5130	rapport	_
27-47	5131-5132	,	_
27-48	5133-5144	disturbance	_
27-49	5145-5147	of	_
27-50	5148-5156	volition	_
27-51	5157-5158	,	_
27-52	5159-5172	preoccupation	_
27-53	5173-5174	,	_
27-54	5175-5180	motor	_
27-55	5181-5192	retardation	_
27-56	5193-5194	)	_
27-57	5195-5196	,	_
27-58	5197-5205	positive	_
27-59	5206-5207	(	_
27-60	5208-5217	delusions	_
27-61	5218-5219	,	_
27-62	5220-5227	unusual	_
27-63	5228-5236	thoughts	_
27-64	5237-5238	,	_
27-65	5239-5246	somatic	_
27-66	5247-5254	concern	_
27-67	5255-5256	,	_
27-68	5257-5268	grandiosity	_
27-69	5269-5270	,	_
27-70	5271-5285	suspiciousness	_
27-71	5286-5287	,	_
27-72	5288-5302	hallucinations	_
27-73	5303-5304	)	_
27-74	5305-5306	,	_
27-75	5307-5316	cognitive	_
27-76	5317-5318	(	_
27-77	5319-5329	difficulty	_
27-78	5330-5332	in	_
27-79	5333-5341	abstract	_
27-80	5342-5350	thinking	_
27-81	5351-5352	,	_
27-82	5353-5364	stereotyped	_
27-83	5365-5373	thinking	_
27-84	5374-5375	,	_
27-85	5376-5385	cognitive	_
27-86	5386-5401	disorganization	_
27-87	5402-5403	,	_
27-88	5404-5408	lack	_
27-89	5409-5411	of	_
27-90	5412-5420	judgment	_
27-91	5421-5424	and	_
27-92	5425-5432	insight	_
27-93	5433-5434	,	_
27-94	5435-5439	poor	_
27-95	5440-5449	attention	_
27-96	5450-5451	,	_
27-97	5452-5459	tension	_
27-98	5460-5461	,	_
27-99	5462-5472	mannerisms	_
27-100	5473-5476	and	_
27-101	5477-5486	posturing	_
27-102	5487-5488	)	_
27-103	5489-5490	,	_
27-104	5491-5500	emotional	_
27-105	5501-5511	discomfort	_
27-106	5512-5513	(	_
27-107	5514-5524	depression	_
27-108	5525-5526	,	_
27-109	5527-5534	anxiety	_
27-110	5535-5536	,	_
27-111	5537-5542	guilt	_
27-112	5543-5544	,	_
27-113	5545-5551	active	_
27-114	5552-5558	social	_
27-115	5559-5568	avoidance	_
27-116	5569-5570	)	_
27-117	5571-5572	,	_
27-118	5573-5576	and	_
27-119	5577-5586	hostility	_
27-120	5587-5588	(	_
27-121	5589-5599	excitement	_
27-122	5600-5601	,	_
27-123	5602-5611	hostility	_
27-124	5612-5613	,	_
27-125	5614-5621	impulse	_
27-126	5622-5629	control	_
27-127	5630-5631	,	_
27-128	5632-5649	uncooperativeness	_
27-129	5650-5651	)	_
27-130	5652-5653	.	_

Text=Auditory stimuli: Passive oddball-omission paradigm ERPs and fMRI were recorded during a sound omission MMN paradigm in which repetitive sequences of a frequent auditory stimulus were omitted occasionally.
28-1	5654-5662	Auditory	_
28-2	5663-5670	stimuli	_
28-3	5671-5672	:	_
28-4	5673-5680	Passive	_
28-5	5681-5697	oddball-omission	_
28-6	5698-5706	paradigm	_
28-7	5707-5711	ERPs	http://maven.renci.org/NeuroBridge/neurobridge#Hyperprolactinemia
28-8	5712-5715	and	_
28-9	5716-5720	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
28-10	5721-5725	were	_
28-11	5726-5734	recorded	_
28-12	5735-5741	during	_
28-13	5742-5743	a	_
28-14	5744-5749	sound	_
28-15	5750-5758	omission	_
28-16	5759-5762	MMN	_
28-17	5763-5771	paradigm	_
28-18	5772-5774	in	_
28-19	5775-5780	which	_
28-20	5781-5791	repetitive	_
28-21	5792-5801	sequences	_
28-22	5802-5804	of	_
28-23	5805-5806	a	_
28-24	5807-5815	frequent	_
28-25	5816-5824	auditory	_
28-26	5825-5833	stimulus	_
28-27	5834-5838	were	_
28-28	5839-5846	omitted	_
28-29	5847-5859	occasionally	_
28-30	5860-5861	.	_

Text=A computer with custom-designed software generated the acoustic stimuli and controlled stimulus timing and presentation.
29-1	5862-5863	A	_
29-2	5864-5872	computer	_
29-3	5873-5877	with	_
29-4	5878-5893	custom-designed	_
29-5	5894-5902	software	_
29-6	5903-5912	generated	_
29-7	5913-5916	the	_
29-8	5917-5925	acoustic	_
29-9	5926-5933	stimuli	_
29-10	5934-5937	and	_
29-11	5938-5948	controlled	_
29-12	5949-5957	stimulus	_
29-13	5958-5964	timing	_
29-14	5965-5968	and	_
29-15	5969-5981	presentation	_
29-16	5982-5983	.	_

Text=Tones were presented binaurally at a constant listening level (92–95 dB sound pressure level) through tube-connected headphones held in place by a headset.
30-1	5984-5989	Tones	_
30-2	5990-5994	were	_
30-3	5995-6004	presented	_
30-4	6005-6015	binaurally	_
30-5	6016-6018	at	_
30-6	6019-6020	a	_
30-7	6021-6029	constant	_
30-8	6030-6039	listening	_
30-9	6040-6045	level	_
30-10	6046-6047	(	_
30-11	6048-6053	92–95	_
30-12	6054-6056	dB	_
30-13	6057-6062	sound	_
30-14	6063-6071	pressure	_
30-15	6072-6077	level	_
30-16	6078-6079	)	_
30-17	6080-6087	through	_
30-18	6088-6102	tube-connected	_
30-19	6103-6113	headphones	_
30-20	6114-6118	held	_
30-21	6119-6121	in	_
30-22	6122-6127	place	_
30-23	6128-6130	by	_
30-24	6131-6132	a	_
30-25	6133-6140	headset	_
30-26	6141-6142	.	_

Text=The acoustic stimuli consisted of sine wave tones with a duration of 35 ms, including 0 ms rise and 5 ms fall times.
31-1	6143-6146	The	_
31-2	6147-6155	acoustic	_
31-3	6156-6163	stimuli	_
31-4	6164-6173	consisted	_
31-5	6174-6176	of	_
31-6	6177-6181	sine	_
31-7	6182-6186	wave	_
31-8	6187-6192	tones	_
31-9	6193-6197	with	_
31-10	6198-6199	a	_
31-11	6200-6208	duration	_
31-12	6209-6211	of	_
31-13	6212-6214	35	_
31-14	6215-6217	ms	_
31-15	6218-6219	,	_
31-16	6220-6229	including	_
31-17	6230-6231	0	_
31-18	6232-6234	ms	_
31-19	6235-6239	rise	_
31-20	6240-6243	and	_
31-21	6244-6245	5	_
31-22	6246-6248	ms	_
31-23	6249-6253	fall	_
31-24	6254-6259	times	_
31-25	6260-6261	.	_

Text=The tone frequency was 3000 Hz, and the onset-to-onset interval was 136 ms.
32-1	6262-6265	The	_
32-2	6266-6270	tone	_
32-3	6271-6280	frequency	_
32-4	6281-6284	was	_
32-5	6285-6289	3000	_
32-6	6290-6292	Hz	_
32-7	6293-6294	,	_
32-8	6295-6298	and	_
32-9	6299-6302	the	_
32-10	6303-6317	onset-to-onset	_
32-11	6318-6326	interval	_
32-12	6327-6330	was	_
32-13	6331-6334	136	_
32-14	6335-6337	ms	_
32-15	6338-6339	.	_

Text=The experimental task consisted of a single block including 6547 tones and 53 omission events.
33-1	6340-6343	The	_
33-2	6344-6356	experimental	_
33-3	6357-6361	task	_
33-4	6362-6371	consisted	_
33-5	6372-6374	of	_
33-6	6375-6376	a	_
33-7	6377-6383	single	_
33-8	6384-6389	block	_
33-9	6390-6399	including	_
33-10	6400-6404	6547	_
33-11	6405-6410	tones	_
33-12	6411-6414	and	_
33-13	6415-6417	53	_
33-14	6418-6426	omission	_
33-15	6427-6433	events	_
33-16	6434-6435	.	_

Text=The probability of omission was 0.00803 (53/6600), and omission occurred in the 19th location in the sound trains during the “ event ” scans.
34-1	6436-6439	The	_
34-2	6440-6451	probability	_
34-3	6452-6454	of	_
34-4	6455-6463	omission	_
34-5	6464-6467	was	_
34-6	6468-6475	0.00803	_
34-7	6476-6477	(	_
34-8	6478-6485	53/6600	_
34-9	6486-6487	)	_
34-10	6488-6489	,	_
34-11	6490-6493	and	_
34-12	6494-6502	omission	_
34-13	6503-6511	occurred	_
34-14	6512-6514	in	_
34-15	6515-6518	the	_
34-16	6519-6523	19th	_
34-17	6524-6532	location	_
34-18	6533-6535	in	_
34-19	6536-6539	the	_
34-20	6540-6545	sound	_
34-21	6546-6552	trains	_
34-22	6553-6559	during	_
34-23	6560-6563	the	_
34-24	6564-6565	“	_
34-25	6566-6571	event	_
34-26	6572-6573	”	_
34-27	6574-6579	scans	_
34-28	6580-6581	.	_

Text=ERPs were recorded in a ‘ passive ’ condition in which the subjects were asked to ignore the stimuli and watch a silent movie projected on a video monitor.
35-1	6582-6586	ERPs	_
35-2	6587-6591	were	_
35-3	6592-6600	recorded	_
35-4	6601-6603	in	_
35-5	6604-6605	a	_
35-6	6606-6607	‘	_
35-7	6608-6615	passive	_
35-8	6616-6617	’	_
35-9	6618-6627	condition	_
35-10	6628-6630	in	_
35-11	6631-6636	which	_
35-12	6637-6640	the	_
35-13	6641-6649	subjects	_
35-14	6650-6654	were	_
35-15	6655-6660	asked	_
35-16	6661-6663	to	_
35-17	6664-6670	ignore	_
35-18	6671-6674	the	_
35-19	6675-6682	stimuli	_
35-20	6683-6686	and	_
35-21	6687-6692	watch	_
35-22	6693-6694	a	_
35-23	6695-6701	silent	_
35-24	6702-6707	movie	_
35-25	6708-6717	projected	_
35-26	6718-6720	on	_
35-27	6721-6722	a	_
35-28	6723-6728	video	_
35-29	6729-6736	monitor	_
35-30	6737-6738	.	_

Text=All subjects were told that they would have to give specific feedback about the movie at the end of the ERP session to standardize their level of attention.
36-1	6739-6742	All	_
36-2	6743-6751	subjects	_
36-3	6752-6756	were	_
36-4	6757-6761	told	_
36-5	6762-6766	that	_
36-6	6767-6771	they	_
36-7	6772-6777	would	_
36-8	6778-6782	have	_
36-9	6783-6785	to	_
36-10	6786-6790	give	_
36-11	6791-6799	specific	_
36-12	6800-6808	feedback	_
36-13	6809-6814	about	_
36-14	6815-6818	the	_
36-15	6819-6824	movie	_
36-16	6825-6827	at	_
36-17	6828-6831	the	_
36-18	6832-6835	end	_
36-19	6836-6838	of	_
36-20	6839-6842	the	_
36-21	6843-6846	ERP	_
36-22	6847-6854	session	_
36-23	6855-6857	to	_
36-24	6858-6869	standardize	_
36-25	6870-6875	their	_
36-26	6876-6881	level	_
36-27	6882-6884	of	_
36-28	6885-6894	attention	_
36-29	6895-6896	.	_

Text=Subjects were also instructed to avoid unnecessary eye movement and blinking during the session.
37-1	6897-6905	Subjects	_
37-2	6906-6910	were	_
37-3	6911-6915	also	_
37-4	6916-6926	instructed	_
37-5	6927-6929	to	_
37-6	6930-6935	avoid	_
37-7	6936-6947	unnecessary	_
37-8	6948-6951	eye	_
37-9	6952-6960	movement	_
37-10	6961-6964	and	_
37-11	6965-6973	blinking	_
37-12	6974-6980	during	_
37-13	6981-6984	the	_
37-14	6985-6992	session	_
37-15	6993-6994	.	_

Text=The 136-ms stimulus onset asynchrony (SOA) of the acoustic stimuli used in the present study was selected to be within the temporal window of integration (TWI) proposed by Yabe et al .. Acoustic signals presented within an approximate 200 ms temporal window are integrated into a single perceptual unit.
38-1	6995-6998	The	_
38-2	6999-7005	136-ms	_
38-3	7006-7014	stimulus	_
38-4	7015-7020	onset	_
38-5	7021-7031	asynchrony	_
38-6	7032-7033	(	_
38-7	7034-7037	SOA	_
38-8	7038-7039	)	_
38-9	7040-7042	of	_
38-10	7043-7046	the	_
38-11	7047-7055	acoustic	_
38-12	7056-7063	stimuli	_
38-13	7064-7068	used	_
38-14	7069-7071	in	_
38-15	7072-7075	the	_
38-16	7076-7083	present	_
38-17	7084-7089	study	_
38-18	7090-7093	was	_
38-19	7094-7102	selected	_
38-20	7103-7105	to	_
38-21	7106-7108	be	_
38-22	7109-7115	within	_
38-23	7116-7119	the	_
38-24	7120-7128	temporal	_
38-25	7129-7135	window	_
38-26	7136-7138	of	_
38-27	7139-7150	integration	_
38-28	7151-7152	(	_
38-29	7153-7156	TWI	_
38-30	7157-7158	)	_
38-31	7159-7167	proposed	_
38-32	7168-7170	by	_
38-33	7171-7175	Yabe	_
38-34	7176-7178	et	_
38-35	7179-7181	al	_
38-36	7182-7184	..	_
38-37	7185-7193	Acoustic	_
38-38	7194-7201	signals	_
38-39	7202-7211	presented	_
38-40	7212-7218	within	_
38-41	7219-7221	an	_
38-42	7222-7233	approximate	_
38-43	7234-7237	200	_
38-44	7238-7240	ms	_
38-45	7241-7249	temporal	_
38-46	7250-7256	window	_
38-47	7257-7260	are	_
38-48	7261-7271	integrated	_
38-49	7272-7276	into	_
38-50	7277-7278	a	_
38-51	7279-7285	single	_
38-52	7286-7296	perceptual	_
38-53	7297-7301	unit	_
38-54	7302-7303	.	_

Text=In addition, Yabe et al.
39-1	7304-7306	In	_
39-2	7307-7315	addition	_
39-3	7316-7317	,	_
39-4	7318-7322	Yabe	_
39-5	7323-7325	et	_
39-6	7326-7328	al	_
39-7	7329-7330	.	_

Text=showed that acoustic information is integrated into a single unit within 160–170 ms to form a sound trace in sensory memory via a stimulus-omission MMN paradigm.
40-1	7331-7337	showed	_
40-2	7338-7342	that	_
40-3	7343-7351	acoustic	_
40-4	7352-7363	information	_
40-5	7364-7366	is	_
40-6	7367-7377	integrated	_
40-7	7378-7382	into	_
40-8	7383-7384	a	_
40-9	7385-7391	single	_
40-10	7392-7396	unit	_
40-11	7397-7403	within	_
40-12	7404-7411	160–170	_
40-13	7412-7414	ms	_
40-14	7415-7417	to	_
40-15	7418-7422	form	_
40-16	7423-7424	a	_
40-17	7425-7430	sound	_
40-18	7431-7436	trace	_
40-19	7437-7439	in	_
40-20	7440-7447	sensory	_
40-21	7448-7454	memory	_
40-22	7455-7458	via	_
40-23	7459-7460	a	_
40-24	7461-7478	stimulus-omission	_
40-25	7479-7482	MMN	_
40-26	7483-7491	paradigm	_
40-27	7492-7493	.	_

Text=TWI is an aspect of temporal integration that determines the initial sound energy unit in the early, pre-attentive stages of auditory information processing.
41-1	7494-7497	TWI	_
41-2	7498-7500	is	_
41-3	7501-7503	an	_
41-4	7504-7510	aspect	_
41-5	7511-7513	of	_
41-6	7514-7522	temporal	_
41-7	7523-7534	integration	_
41-8	7535-7539	that	_
41-9	7540-7550	determines	_
41-10	7551-7554	the	_
41-11	7555-7562	initial	_
41-12	7563-7568	sound	_
41-13	7569-7575	energy	_
41-14	7576-7580	unit	_
41-15	7581-7583	in	_
41-16	7584-7587	the	_
41-17	7588-7593	early	_
41-18	7594-7595	,	_
41-19	7596-7609	pre-attentive	_
41-20	7610-7616	stages	_
41-21	7617-7619	of	_
41-22	7620-7628	auditory	_
41-23	7629-7640	information	_
41-24	7641-7651	processing	_
41-25	7652-7653	.	_

Text=fMRI design and synchronization between scan noise and auditory stimuli We used an event-related design for the fMRI.
42-1	7654-7658	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
42-2	7659-7665	design	_
42-3	7666-7669	and	_
42-4	7670-7685	synchronization	_
42-5	7686-7693	between	_
42-6	7694-7698	scan	_
42-7	7699-7704	noise	_
42-8	7705-7708	and	_
42-9	7709-7717	auditory	_
42-10	7718-7725	stimuli	_
42-11	7726-7728	We	_
42-12	7729-7733	used	_
42-13	7734-7736	an	_
42-14	7737-7750	event-related	_
42-15	7751-7757	design	_
42-16	7758-7761	for	_
42-17	7762-7765	the	_
42-18	7766-7770	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
42-19	7771-7772	.	_

Text=Scans of 22 slices generated equal numbers of scan noises during a single repetition time (TR) of 2992 ms, and the same number of tones with an SOA of 136 ms (TR/slice number = 2992/22) were presented.
43-1	7773-7778	Scans	_
43-2	7779-7781	of	_
43-3	7782-7784	22	_
43-4	7785-7791	slices	_
43-5	7792-7801	generated	_
43-6	7802-7807	equal	_
43-7	7808-7815	numbers	_
43-8	7816-7818	of	_
43-9	7819-7823	scan	_
43-10	7824-7830	noises	_
43-11	7831-7837	during	_
43-12	7838-7839	a	_
43-13	7840-7846	single	_
43-14	7847-7857	repetition	_
43-15	7858-7862	time	_
43-16	7863-7864	(	_
43-17	7865-7867	TR	_
43-18	7868-7869	)	_
43-19	7870-7872	of	_
43-20	7873-7877	2992	_
43-21	7878-7880	ms	_
43-22	7881-7882	,	_
43-23	7883-7886	and	_
43-24	7887-7890	the	_
43-25	7891-7895	same	_
43-26	7896-7902	number	_
43-27	7903-7905	of	_
43-28	7906-7911	tones	_
43-29	7912-7916	with	_
43-30	7917-7919	an	_
43-31	7920-7923	SOA	_
43-32	7924-7926	of	_
43-33	7927-7930	136	_
43-34	7931-7933	ms	_
43-35	7934-7935	(	_
43-36	7936-7944	TR/slice	_
43-37	7945-7951	number	_
43-38	7952-7953	=	_
43-39	7954-7961	2992/22	_
43-40	7962-7963	)	_
43-41	7964-7968	were	_
43-42	7969-7978	presented	_
43-43	7979-7980	.	_

Text=The presentation of tones was completely synchronized to scans by triggers generated by the MRI system in order to minimize the effect of scan noise on fMRI and EEG raw data, which were also used to segregate and average EEG epochs in the ERP analysis.
44-1	7981-7984	The	_
44-2	7985-7997	presentation	_
44-3	7998-8000	of	_
44-4	8001-8006	tones	_
44-5	8007-8010	was	_
44-6	8011-8021	completely	_
44-7	8022-8034	synchronized	_
44-8	8035-8037	to	_
44-9	8038-8043	scans	_
44-10	8044-8046	by	_
44-11	8047-8055	triggers	_
44-12	8056-8065	generated	_
44-13	8066-8068	by	_
44-14	8069-8072	the	_
44-15	8073-8076	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
44-16	8077-8083	system	_
44-17	8084-8086	in	_
44-18	8087-8092	order	_
44-19	8093-8095	to	_
44-20	8096-8104	minimize	_
44-21	8105-8108	the	_
44-22	8109-8115	effect	_
44-23	8116-8118	of	_
44-24	8119-8123	scan	_
44-25	8124-8129	noise	_
44-26	8130-8132	on	_
44-27	8133-8137	fMRI	_
44-28	8138-8141	and	_
44-29	8142-8145	EEG	_
44-30	8146-8149	raw	_
44-31	8150-8154	data	_
44-32	8155-8156	,	_
44-33	8157-8162	which	_
44-34	8163-8167	were	_
44-35	8168-8172	also	_
44-36	8173-8177	used	_
44-37	8178-8180	to	_
44-38	8181-8190	segregate	_
44-39	8191-8194	and	_
44-40	8195-8202	average	_
44-41	8203-8206	EEG	_
44-42	8207-8213	epochs	_
44-43	8214-8216	in	_
44-44	8217-8220	the	_
44-45	8221-8224	ERP	_
44-46	8225-8233	analysis	_
44-47	8234-8235	.	_

Text=We averaged EEG epochs and subtracted the waveforms of the baseline tones from the omission events during ERP processing to eliminate fluctuations in the EEG signals due to scan noise.
45-1	8236-8238	We	_
45-2	8239-8247	averaged	_
45-3	8248-8251	EEG	_
45-4	8252-8258	epochs	_
45-5	8259-8262	and	_
45-6	8263-8273	subtracted	_
45-7	8274-8277	the	_
45-8	8278-8287	waveforms	_
45-9	8288-8290	of	_
45-10	8291-8294	the	_
45-11	8295-8303	baseline	_
45-12	8304-8309	tones	_
45-13	8310-8314	from	_
45-14	8315-8318	the	_
45-15	8319-8327	omission	_
45-16	8328-8334	events	_
45-17	8335-8341	during	_
45-18	8342-8345	ERP	_
45-19	8346-8356	processing	_
45-20	8357-8359	to	_
45-21	8360-8369	eliminate	_
45-22	8370-8382	fluctuations	_
45-23	8383-8385	in	_
45-24	8386-8389	the	_
45-25	8390-8393	EEG	_
45-26	8394-8401	signals	_
45-27	8402-8405	due	_
45-28	8406-8408	to	_
45-29	8409-8413	scan	_
45-30	8414-8419	noise	_
45-31	8420-8421	.	_

Text=A similar concept was applied for blood oxygen level-dependent (BOLD) signal processing using an event-related fMRI design.
46-1	8422-8423	A	_
46-2	8424-8431	similar	_
46-3	8432-8439	concept	_
46-4	8440-8443	was	_
46-5	8444-8451	applied	_
46-6	8452-8455	for	_
46-7	8456-8461	blood	_
46-8	8462-8468	oxygen	_
46-9	8469-8484	level-dependent	_
46-10	8485-8486	(	_
46-11	8487-8491	BOLD	_
46-12	8492-8493	)	_
46-13	8494-8500	signal	_
46-14	8501-8511	processing	_
46-15	8512-8517	using	_
46-16	8518-8520	an	_
46-17	8521-8534	event-related	_
46-18	8535-8539	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
46-19	8540-8546	design	_
46-20	8547-8548	.	_

Text=The SOA for event scans including the omission events and tones in the regular positions represent 7 or 8 scans (20,944 or 23,936 ms).
47-1	8549-8552	The	_
47-2	8553-8556	SOA	_
47-3	8557-8560	for	_
47-4	8561-8566	event	_
47-5	8567-8572	scans	_
47-6	8573-8582	including	_
47-7	8583-8586	the	_
47-8	8587-8595	omission	_
47-9	8596-8602	events	_
47-10	8603-8606	and	_
47-11	8607-8612	tones	_
47-12	8613-8615	in	_
47-13	8616-8619	the	_
47-14	8620-8627	regular	_
47-15	8628-8637	positions	_
47-16	8638-8647	represent	_
47-17	8648-8649	7	_
47-18	8650-8652	or	_
47-19	8653-8654	8	_
47-20	8655-8660	scans	_
47-21	8661-8662	(	_
47-22	8663-8669	20,944	_
47-23	8670-8672	or	_
47-24	8673-8679	23,936	_
47-25	8680-8682	ms	_
47-26	8683-8684	)	_
47-27	8685-8686	.	_

Text=Fifty-three event scans were assorted at random among the 247 baseline scans including baseline tones only, with no omission (Fig 1).
48-1	8687-8698	Fifty-three	_
48-2	8699-8704	event	_
48-3	8705-8710	scans	_
48-4	8711-8715	were	_
48-5	8716-8724	assorted	_
48-6	8725-8727	at	_
48-7	8728-8734	random	_
48-8	8735-8740	among	_
48-9	8741-8744	the	_
48-10	8745-8748	247	_
48-11	8749-8757	baseline	_
48-12	8758-8763	scans	_
48-13	8764-8773	including	_
48-14	8774-8782	baseline	_
48-15	8783-8788	tones	_
48-16	8789-8793	only	_
48-17	8794-8795	,	_
48-18	8796-8800	with	_
48-19	8801-8803	no	_
48-20	8804-8812	omission	_
48-21	8813-8814	(	_
48-22	8815-8818	Fig	_
48-23	8819-8820	1	_
48-24	8821-8822	)	_
48-25	8823-8824	.	_

Text=BOLD hemodynamic responses for event scans were then compared to those for baseline scans.
49-1	8825-8829	BOLD	_
49-2	8830-8841	hemodynamic	_
49-3	8842-8851	responses	_
49-4	8852-8855	for	_
49-5	8856-8861	event	_
49-6	8862-8867	scans	_
49-7	8868-8872	were	_
49-8	8873-8877	then	_
49-9	8878-8886	compared	_
49-10	8887-8889	to	_
49-11	8890-8895	those	_
49-12	8896-8899	for	_
49-13	8900-8908	baseline	_
49-14	8909-8914	scans	_
49-15	8915-8916	.	_

Text=Image acquisition for fMRI BOLD fMRI data acquisition was performed at Juntendo University Hospital using a Philips Achieva 3.0 Tesla MRI scanner with a T2 * -weighted gradient-echo echo-planar imaging (EPI) sequence and 8-channel array receiving head coil for sensitivity-encoding parallel imaging.
50-1	8917-8922	Image	_
50-2	8923-8934	acquisition	_
50-3	8935-8938	for	_
50-4	8939-8943	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
50-5	8944-8948	BOLD	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
50-6	8949-8953	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
50-7	8954-8958	data	_
50-8	8959-8970	acquisition	_
50-9	8971-8974	was	_
50-10	8975-8984	performed	_
50-11	8985-8987	at	_
50-12	8988-8996	Juntendo	_
50-13	8997-9007	University	_
50-14	9008-9016	Hospital	_
50-15	9017-9022	using	_
50-16	9023-9024	a	_
50-17	9025-9032	Philips	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
50-18	9033-9040	Achieva	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
50-19	9041-9044	3.0	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
50-20	9045-9050	Tesla	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
50-21	9051-9054	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
50-22	9055-9062	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
50-23	9063-9067	with	_
50-24	9068-9069	a	_
50-25	9070-9072	T2	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-26	9073-9074	*	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-27	9075-9084	-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-28	9085-9098	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-29	9099-9110	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-30	9111-9118	imaging	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-31	9119-9120	(	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-32	9121-9124	EPI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-33	9125-9126	)	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-34	9127-9135	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
50-35	9136-9139	and	_
50-36	9140-9149	8-channel	_
50-37	9150-9155	array	_
50-38	9156-9165	receiving	_
50-39	9166-9170	head	_
50-40	9171-9175	coil	_
50-41	9176-9179	for	_
50-42	9180-9200	sensitivity-encoding	_
50-43	9201-9209	parallel	_
50-44	9210-9217	imaging	_
50-45	9218-9219	.	_

Text=The parameters were as follows: echo time (TE) = 35 ms, TR = 2992 ms, field of view (FOV) = 240 × 240 mm, matrix = 96 × 96, flip angle = 90°, number of axial slices = 22, and voxel size = 2.5 × 2.5 × 6.0 mm.
51-1	9220-9223	The	_
51-2	9224-9234	parameters	_
51-3	9235-9239	were	_
51-4	9240-9242	as	_
51-5	9243-9250	follows	_
51-6	9251-9252	:	_
51-7	9253-9257	echo	_
51-8	9258-9262	time	_
51-9	9263-9264	(	_
51-10	9265-9267	TE	_
51-11	9268-9269	)	_
51-12	9270-9271	=	_
51-13	9272-9274	35	_
51-14	9275-9277	ms	_
51-15	9278-9279	,	_
51-16	9280-9282	TR	_
51-17	9283-9284	=	_
51-18	9285-9289	2992	_
51-19	9290-9292	ms	_
51-20	9293-9294	,	_
51-21	9295-9300	field	_
51-22	9301-9303	of	_
51-23	9304-9308	view	_
51-24	9309-9310	(	_
51-25	9311-9314	FOV	_
51-26	9315-9316	)	_
51-27	9317-9318	=	_
51-28	9319-9322	240	_
51-29	9323-9324	×	_
51-30	9325-9328	240	_
51-31	9329-9331	mm	_
51-32	9332-9333	,	_
51-33	9334-9340	matrix	_
51-34	9341-9342	=	_
51-35	9343-9345	96	_
51-36	9346-9347	×	_
51-37	9348-9350	96	_
51-38	9351-9352	,	_
51-39	9353-9357	flip	_
51-40	9358-9363	angle	_
51-41	9364-9365	=	_
51-42	9366-9369	90°	_
51-43	9370-9371	,	_
51-44	9372-9378	number	_
51-45	9379-9381	of	_
51-46	9382-9387	axial	_
51-47	9388-9394	slices	_
51-48	9395-9396	=	_
51-49	9397-9399	22	_
51-50	9400-9401	,	_
51-51	9402-9405	and	_
51-52	9406-9411	voxel	_
51-53	9412-9416	size	_
51-54	9417-9418	=	_
51-55	9419-9422	2.5	_
51-56	9423-9424	×	_
51-57	9425-9428	2.5	_
51-58	9429-9430	×	_
51-59	9431-9434	6.0	_
51-60	9435-9437	mm	_
51-61	9438-9439	.	_

Text=Three hundred scans were collected in each session (total time = 2992 ms × 300 = 897,600 ms).
52-1	9440-9445	Three	_
52-2	9446-9453	hundred	_
52-3	9454-9459	scans	_
52-4	9460-9464	were	_
52-5	9465-9474	collected	_
52-6	9475-9477	in	_
52-7	9478-9482	each	_
52-8	9483-9490	session	_
52-9	9491-9492	(	_
52-10	9493-9498	total	_
52-11	9499-9503	time	_
52-12	9504-9505	=	_
52-13	9506-9510	2992	_
52-14	9511-9513	ms	_
52-15	9514-9515	×	_
52-16	9516-9519	300	_
52-17	9520-9521	=	_
52-18	9522-9529	897,600	_
52-19	9530-9532	ms	_
52-20	9533-9534	)	_
52-21	9535-9536	.	_

Text=Image processing As described in detail previously, imaging data were preprocessed and voxel-based statistical analysis performed using SPM8 software (Wellcome Department of Imaging Neuroscience) running on MATLAB (version 8.3.0, Math Works Inc., 2014).
53-1	9537-9542	Image	_
53-2	9543-9553	processing	_
53-3	9554-9556	As	_
53-4	9557-9566	described	_
53-5	9567-9569	in	_
53-6	9570-9576	detail	_
53-7	9577-9587	previously	_
53-8	9588-9589	,	_
53-9	9590-9597	imaging	_
53-10	9598-9602	data	_
53-11	9603-9607	were	_
53-12	9608-9620	preprocessed	_
53-13	9621-9624	and	_
53-14	9625-9636	voxel-based	_
53-15	9637-9648	statistical	_
53-16	9649-9657	analysis	_
53-17	9658-9667	performed	_
53-18	9668-9673	using	_
53-19	9674-9678	SPM8	_
53-20	9679-9687	software	_
53-21	9688-9689	(	_
53-22	9690-9698	Wellcome	_
53-23	9699-9709	Department	_
53-24	9710-9712	of	_
53-25	9713-9720	Imaging	_
53-26	9721-9733	Neuroscience	_
53-27	9734-9735	)	_
53-28	9736-9743	running	_
53-29	9744-9746	on	_
53-30	9747-9753	MATLAB	_
53-31	9754-9755	(	_
53-32	9756-9763	version	_
53-33	9764-9769	8.3.0	_
53-34	9770-9771	,	_
53-35	9772-9776	Math	_
53-36	9777-9782	Works	_
53-37	9783-9787	Inc.	_
53-38	9788-9789	,	_
53-39	9790-9794	2014	_
53-40	9795-9796	)	_
53-41	9797-9798	.	_

Text=The first four volumes were discarded, and the remaining 296 volumes were preprocessed.
54-1	9799-9802	The	_
54-2	9803-9808	first	_
54-3	9809-9813	four	_
54-4	9814-9821	volumes	_
54-5	9822-9826	were	_
54-6	9827-9836	discarded	_
54-7	9837-9838	,	_
54-8	9839-9842	and	_
54-9	9843-9846	the	_
54-10	9847-9856	remaining	_
54-11	9857-9860	296	_
54-12	9861-9868	volumes	_
54-13	9869-9873	were	_
54-14	9874-9886	preprocessed	_
54-15	9887-9888	.	_

Text=Preprocessing steps prior to statistical analysis included slice time correction, motion correction, and spatial normalization to a standard template in Montreal Neurological Institute (MNI) space.
55-1	9889-9902	Preprocessing	_
55-2	9903-9908	steps	_
55-3	9909-9914	prior	_
55-4	9915-9917	to	_
55-5	9918-9929	statistical	_
55-6	9930-9938	analysis	_
55-7	9939-9947	included	_
55-8	9948-9953	slice	_
55-9	9954-9958	time	_
55-10	9959-9969	correction	_
55-11	9970-9971	,	_
55-12	9972-9978	motion	_
55-13	9979-9989	correction	_
55-14	9990-9991	,	_
55-15	9992-9995	and	_
55-16	9996-10003	spatial	_
55-17	10004-10017	normalization	_
55-18	10018-10020	to	_
55-19	10021-10022	a	_
55-20	10023-10031	standard	_
55-21	10032-10040	template	_
55-22	10041-10043	in	_
55-23	10044-10052	Montreal	_
55-24	10053-10065	Neurological	_
55-25	10066-10075	Institute	_
55-26	10076-10077	(	_
55-27	10078-10081	MNI	_
55-28	10082-10083	)	_
55-29	10084-10089	space	_
55-30	10090-10091	.	_

Text=The slice timing was corrected according to the slice order and the fMRI data realigned and subsequently normalized to the standard MNI template using the T1 SPM template, resulting in voxels of 2 × 2 × 2 mm.
56-1	10092-10095	The	_
56-2	10096-10101	slice	_
56-3	10102-10108	timing	_
56-4	10109-10112	was	_
56-5	10113-10122	corrected	_
56-6	10123-10132	according	_
56-7	10133-10135	to	_
56-8	10136-10139	the	_
56-9	10140-10145	slice	_
56-10	10146-10151	order	_
56-11	10152-10155	and	_
56-12	10156-10159	the	_
56-13	10160-10164	fMRI	_
56-14	10165-10169	data	_
56-15	10170-10179	realigned	_
56-16	10180-10183	and	_
56-17	10184-10196	subsequently	_
56-18	10197-10207	normalized	_
56-19	10208-10210	to	_
56-20	10211-10214	the	_
56-21	10215-10223	standard	_
56-22	10224-10227	MNI	_
56-23	10228-10236	template	_
56-24	10237-10242	using	_
56-25	10243-10246	the	_
56-26	10247-10249	T1	_
56-27	10250-10253	SPM	_
56-28	10254-10262	template	_
56-29	10263-10264	,	_
56-30	10265-10274	resulting	_
56-31	10275-10277	in	_
56-32	10278-10284	voxels	_
56-33	10285-10287	of	_
56-34	10288-10289	2	_
56-35	10290-10291	×	_
56-36	10292-10293	2	_
56-37	10294-10295	×	_
56-38	10296-10297	2	_
56-39	10298-10300	mm	_
56-40	10301-10302	.	_

Text=All functional images were spatially smoothed using a Gaussian filter kernel (full width at half maximum [FWHM] 8 mm) and the data bandpass filtered (0.008–0.09 Hz).
57-1	10303-10306	All	_
57-2	10307-10317	functional	_
57-3	10318-10324	images	_
57-4	10325-10329	were	_
57-5	10330-10339	spatially	_
57-6	10340-10348	smoothed	_
57-7	10349-10354	using	_
57-8	10355-10356	a	_
57-9	10357-10365	Gaussian	_
57-10	10366-10372	filter	_
57-11	10373-10379	kernel	_
57-12	10380-10381	(	_
57-13	10382-10386	full	_
57-14	10387-10392	width	_
57-15	10393-10395	at	_
57-16	10396-10400	half	_
57-17	10401-10408	maximum	_
57-18	10409-10410	[	_
57-19	10411-10415	FWHM	_
57-20	10416-10417	]	_
57-21	10418-10419	8	_
57-22	10420-10422	mm	_
57-23	10423-10424	)	_
57-24	10425-10428	and	_
57-25	10429-10432	the	_
57-26	10433-10437	data	_
57-27	10438-10446	bandpass	_
57-28	10447-10455	filtered	_
57-29	10456-10457	(	_
57-30	10458-10468	0.008–0.09	_
57-31	10469-10471	Hz	_
57-32	10472-10473	)	_
57-33	10474-10475	.	_

Text=Image artifacts originating from head movement were handled using the ART scrubbing procedure (www.nitrc.org/projects/artifact_detect/), and signal contributions from white brain matter, cerebrospinal fluid, and micro head-movement (six parameters) were discerned from the data.
58-1	10476-10481	Image	_
58-2	10482-10491	artifacts	_
58-3	10492-10503	originating	_
58-4	10504-10508	from	_
58-5	10509-10513	head	_
58-6	10514-10522	movement	_
58-7	10523-10527	were	_
58-8	10528-10535	handled	_
58-9	10536-10541	using	_
58-10	10542-10545	the	_
58-11	10546-10549	ART	_
58-12	10550-10559	scrubbing	_
58-13	10560-10569	procedure	_
58-14	10570-10571	(	_
58-15	10572-10611	www.nitrc.org/projects/artifact_detect/	_
58-16	10612-10613	)	_
58-17	10614-10615	,	_
58-18	10616-10619	and	_
58-19	10620-10626	signal	_
58-20	10627-10640	contributions	_
58-21	10641-10645	from	_
58-22	10646-10651	white	_
58-23	10652-10657	brain	_
58-24	10658-10664	matter	_
58-25	10665-10666	,	_
58-26	10667-10680	cerebrospinal	_
58-27	10681-10686	fluid	_
58-28	10687-10688	,	_
58-29	10689-10692	and	_
58-30	10693-10698	micro	_
58-31	10699-10712	head-movement	_
58-32	10713-10714	(	_
58-33	10715-10718	six	_
58-34	10719-10729	parameters	_
58-35	10730-10731	)	_
58-36	10732-10736	were	_
58-37	10737-10746	discerned	_
58-38	10747-10751	from	_
58-39	10752-10755	the	_
58-40	10756-10760	data	_
58-41	10761-10762	.	_

Text=The six realignment parameters were included in the design matrix to correct for signal changes caused by head movement.
59-1	10763-10766	The	_
59-2	10767-10770	six	_
59-3	10771-10782	realignment	_
59-4	10783-10793	parameters	_
59-5	10794-10798	were	_
59-6	10799-10807	included	_
59-7	10808-10810	in	_
59-8	10811-10814	the	_
59-9	10815-10821	design	_
59-10	10822-10828	matrix	_
59-11	10829-10831	to	_
59-12	10832-10839	correct	_
59-13	10840-10843	for	_
59-14	10844-10850	signal	_
59-15	10851-10858	changes	_
59-16	10859-10865	caused	_
59-17	10866-10868	by	_
59-18	10869-10873	head	_
59-19	10874-10882	movement	_
59-20	10883-10884	.	_

Text=Event conditions (omission vs. baseline) were modeled using the standard hemodynamic response function.
60-1	10885-10890	Event	_
60-2	10891-10901	conditions	_
60-3	10902-10903	(	_
60-4	10904-10912	omission	_
60-5	10913-10916	vs.	_
60-6	10917-10925	baseline	_
60-7	10926-10927	)	_
60-8	10928-10932	were	_
60-9	10933-10940	modeled	_
60-10	10941-10946	using	_
60-11	10947-10950	the	_
60-12	10951-10959	standard	_
60-13	10960-10971	hemodynamic	_
60-14	10972-10980	response	_
60-15	10981-10989	function	_
60-16	10990-10991	.	_

Text=First level analysis of individual participant images was performed to produce estimates for the contrast of interest (omission vs. tones) according to the general linear model (GLM), and significant signal changes in the contrast were assessed using F-statistics on a voxel-by-voxel basis.
61-1	10992-10997	First	_
61-2	10998-11003	level	_
61-3	11004-11012	analysis	_
61-4	11013-11015	of	_
61-5	11016-11026	individual	_
61-6	11027-11038	participant	_
61-7	11039-11045	images	_
61-8	11046-11049	was	_
61-9	11050-11059	performed	_
61-10	11060-11062	to	_
61-11	11063-11070	produce	_
61-12	11071-11080	estimates	_
61-13	11081-11084	for	_
61-14	11085-11088	the	_
61-15	11089-11097	contrast	_
61-16	11098-11100	of	_
61-17	11101-11109	interest	_
61-18	11110-11111	(	_
61-19	11112-11120	omission	_
61-20	11121-11124	vs.	_
61-21	11125-11130	tones	_
61-22	11131-11132	)	_
61-23	11133-11142	according	_
61-24	11143-11145	to	_
61-25	11146-11149	the	_
61-26	11150-11157	general	_
61-27	11158-11164	linear	_
61-28	11165-11170	model	_
61-29	11171-11172	(	_
61-30	11173-11176	GLM	_
61-31	11177-11178	)	_
61-32	11179-11180	,	_
61-33	11181-11184	and	_
61-34	11185-11196	significant	_
61-35	11197-11203	signal	_
61-36	11204-11211	changes	_
61-37	11212-11214	in	_
61-38	11215-11218	the	_
61-39	11219-11227	contrast	_
61-40	11228-11232	were	_
61-41	11233-11241	assessed	_
61-42	11242-11247	using	_
61-43	11248-11260	F-statistics	_
61-44	11261-11263	on	_
61-45	11264-11265	a	_
61-46	11266-11280	voxel-by-voxel	_
61-47	11281-11286	basis	_
61-48	11287-11288	.	_

Text=The resulting set of voxel values for the contrast constituted statistical parametric mapping (SPM) of the F-statistic.
62-1	11289-11292	The	_
62-2	11293-11302	resulting	_
62-3	11303-11306	set	_
62-4	11307-11309	of	_
62-5	11310-11315	voxel	_
62-6	11316-11322	values	_
62-7	11323-11326	for	_
62-8	11327-11330	the	_
62-9	11331-11339	contrast	_
62-10	11340-11351	constituted	_
62-11	11352-11363	statistical	_
62-12	11364-11374	parametric	_
62-13	11375-11382	mapping	_
62-14	11383-11384	(	_
62-15	11385-11388	SPM	_
62-16	11389-11390	)	_
62-17	11391-11393	of	_
62-18	11394-11397	the	_
62-19	11398-11409	F-statistic	_
62-20	11410-11411	.	_

Text=Second level analysis was performed on contrast images in a group random-effects analysis using a one-sample t-test.
63-1	11412-11418	Second	_
63-2	11419-11424	level	_
63-3	11425-11433	analysis	_
63-4	11434-11437	was	_
63-5	11438-11447	performed	_
63-6	11448-11450	on	_
63-7	11451-11459	contrast	_
63-8	11460-11466	images	_
63-9	11467-11469	in	_
63-10	11470-11471	a	_
63-11	11472-11477	group	_
63-12	11478-11492	random-effects	_
63-13	11493-11501	analysis	_
63-14	11502-11507	using	_
63-15	11508-11509	a	_
63-16	11510-11520	one-sample	_
63-17	11521-11527	t-test	_
63-18	11528-11529	.	_

Text=Two-sample t-tests between groups were performed with age and education as covariates (significance threshold p <0.05, family-wise error [FWE] corrected).
64-1	11530-11540	Two-sample	_
64-2	11541-11548	t-tests	_
64-3	11549-11556	between	_
64-4	11557-11563	groups	_
64-5	11564-11568	were	_
64-6	11569-11578	performed	_
64-7	11579-11583	with	_
64-8	11584-11587	age	_
64-9	11588-11591	and	_
64-10	11592-11601	education	_
64-11	11602-11604	as	_
64-12	11605-11615	covariates	_
64-13	11616-11617	(	_
64-14	11618-11630	significance	_
64-15	11631-11640	threshold	_
64-16	11641-11642	p	_
64-17	11643-11644	<	_
64-18	11645-11649	0.05	_
64-19	11650-11651	,	_
64-20	11652-11663	family-wise	_
64-21	11664-11669	error	_
64-22	11670-11671	[	_
64-23	11672-11675	FWE	_
64-24	11676-11677	]	_
64-25	11678-11687	corrected	_
64-26	11688-11689	)	_
64-27	11690-11691	.	_

Text=Correlation analysis was also performed between BOLD activities and other factors, including the PANSS, ERP, and DTI data.
65-1	11692-11703	Correlation	_
65-2	11704-11712	analysis	_
65-3	11713-11716	was	_
65-4	11717-11721	also	_
65-5	11722-11731	performed	_
65-6	11732-11739	between	_
65-7	11740-11744	BOLD	_
65-8	11745-11755	activities	_
65-9	11756-11759	and	_
65-10	11760-11765	other	_
65-11	11766-11773	factors	_
65-12	11774-11775	,	_
65-13	11776-11785	including	_
65-14	11786-11789	the	_
65-15	11790-11795	PANSS	_
65-16	11796-11797	,	_
65-17	11798-11801	ERP	_
65-18	11802-11803	,	_
65-19	11804-11807	and	_
65-20	11808-11811	DTI	_
65-21	11812-11816	data	_
65-22	11817-11818	.	_

Text=The activated images were superimposed on the standardized T1-weighted images, and the MNI coordinates of the maximum response in the activated regions presented in SPM8 were converted to Talairach coordinates using the algorithm reported by Lacadie et al .. Talairach labels of activated regions were detected using the Talairach client version 2.4.2 (http: //www.talairach.org/client.html).
66-1	11819-11822	The	_
66-2	11823-11832	activated	_
66-3	11833-11839	images	_
66-4	11840-11844	were	_
66-5	11845-11857	superimposed	_
66-6	11858-11860	on	_
66-7	11861-11864	the	_
66-8	11865-11877	standardized	_
66-9	11878-11889	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
66-10	11890-11896	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
66-11	11897-11898	,	_
66-12	11899-11902	and	_
66-13	11903-11906	the	_
66-14	11907-11910	MNI	_
66-15	11911-11922	coordinates	_
66-16	11923-11925	of	_
66-17	11926-11929	the	_
66-18	11930-11937	maximum	_
66-19	11938-11946	response	_
66-20	11947-11949	in	_
66-21	11950-11953	the	_
66-22	11954-11963	activated	_
66-23	11964-11971	regions	_
66-24	11972-11981	presented	_
66-25	11982-11984	in	_
66-26	11985-11989	SPM8	_
66-27	11990-11994	were	_
66-28	11995-12004	converted	_
66-29	12005-12007	to	_
66-30	12008-12017	Talairach	_
66-31	12018-12029	coordinates	_
66-32	12030-12035	using	_
66-33	12036-12039	the	_
66-34	12040-12049	algorithm	_
66-35	12050-12058	reported	_
66-36	12059-12061	by	_
66-37	12062-12069	Lacadie	_
66-38	12070-12072	et	_
66-39	12073-12075	al	_
66-40	12076-12078	..	_
66-41	12079-12088	Talairach	_
66-42	12089-12095	labels	_
66-43	12096-12098	of	_
66-44	12099-12108	activated	_
66-45	12109-12116	regions	_
66-46	12117-12121	were	_
66-47	12122-12130	detected	_
66-48	12131-12136	using	_
66-49	12137-12140	the	_
66-50	12141-12150	Talairach	_
66-51	12151-12157	client	_
66-52	12158-12165	version	_
66-53	12166-12171	2.4.2	_
66-54	12172-12173	(	_
66-55	12174-12178	http	_
66-56	12179-12180	:	_
66-57	12181-12212	//www.talairach.org/client.html	_
66-58	12213-12214	)	_
66-59	12215-12216	.	_

Text=ROI analysis Quantitative analysis of the event-related fMRI data was performed using the region of interest (ROI) method centered on our areas of interest in the cingulate cortex and temporal lobe.
67-1	12217-12220	ROI	_
67-2	12221-12229	analysis	_
67-3	12230-12242	Quantitative	_
67-4	12243-12251	analysis	_
67-5	12252-12254	of	_
67-6	12255-12258	the	_
67-7	12259-12272	event-related	_
67-8	12273-12277	fMRI	_
67-9	12278-12282	data	_
67-10	12283-12286	was	_
67-11	12287-12296	performed	_
67-12	12297-12302	using	_
67-13	12303-12306	the	_
67-14	12307-12313	region	_
67-15	12314-12316	of	_
67-16	12317-12325	interest	_
67-17	12326-12327	(	_
67-18	12328-12331	ROI	_
67-19	12332-12333	)	_
67-20	12334-12340	method	_
67-21	12341-12349	centered	_
67-22	12350-12352	on	_
67-23	12353-12356	our	_
67-24	12357-12362	areas	_
67-25	12363-12365	of	_
67-26	12366-12374	interest	_
67-27	12375-12377	in	_
67-28	12378-12381	the	_
67-29	12382-12391	cingulate	_
67-30	12392-12398	cortex	_
67-31	12399-12402	and	_
67-32	12403-12411	temporal	_
67-33	12412-12416	lobe	_
67-34	12417-12418	.	_

Text=Estimates of BOLD signal (%) and t-value changes at sound omission were also extracted from select ROIs, including the anterior (S1A Fig) and middle cingulate cortex (S1B Fig), superior and middle temporal gyrus (S1C Fig), and Heschl ’ s gyrus (HSC; S1D Fig), for each participant using the MarsBar SPM toolbox (MRC Cognition and Brain Sciences Unit, Cambridge, UK; http: //marsbar.sourceforge.net).
68-1	12419-12428	Estimates	_
68-2	12429-12431	of	_
68-3	12432-12436	BOLD	_
68-4	12437-12443	signal	_
68-5	12444-12445	(	_
68-6	12446-12447	%	_
68-7	12448-12449	)	_
68-8	12450-12453	and	_
68-9	12454-12461	t-value	_
68-10	12462-12469	changes	_
68-11	12470-12472	at	_
68-12	12473-12478	sound	_
68-13	12479-12487	omission	_
68-14	12488-12492	were	_
68-15	12493-12497	also	_
68-16	12498-12507	extracted	_
68-17	12508-12512	from	_
68-18	12513-12519	select	_
68-19	12520-12524	ROIs	_
68-20	12525-12526	,	_
68-21	12527-12536	including	_
68-22	12537-12540	the	_
68-23	12541-12549	anterior	_
68-24	12550-12551	(	_
68-25	12552-12555	S1A	_
68-26	12556-12559	Fig	_
68-27	12560-12561	)	_
68-28	12562-12565	and	_
68-29	12566-12572	middle	_
68-30	12573-12582	cingulate	_
68-31	12583-12589	cortex	_
68-32	12590-12591	(	_
68-33	12592-12595	S1B	_
68-34	12596-12599	Fig	_
68-35	12600-12601	)	_
68-36	12602-12603	,	_
68-37	12604-12612	superior	_
68-38	12613-12616	and	_
68-39	12617-12623	middle	_
68-40	12624-12632	temporal	_
68-41	12633-12638	gyrus	_
68-42	12639-12640	(	_
68-43	12641-12644	S1C	_
68-44	12645-12648	Fig	_
68-45	12649-12650	)	_
68-46	12651-12652	,	_
68-47	12653-12656	and	_
68-48	12657-12663	Heschl	_
68-49	12664-12665	’	_
68-50	12666-12667	s	_
68-51	12668-12673	gyrus	_
68-52	12674-12675	(	_
68-53	12676-12679	HSC	_
68-54	12680-12681	;	_
68-55	12682-12685	S1D	_
68-56	12686-12689	Fig	_
68-57	12690-12691	)	_
68-58	12692-12693	,	_
68-59	12694-12697	for	_
68-60	12698-12702	each	_
68-61	12703-12714	participant	_
68-62	12715-12720	using	_
68-63	12721-12724	the	_
68-64	12725-12732	MarsBar	_
68-65	12733-12736	SPM	_
68-66	12737-12744	toolbox	_
68-67	12745-12746	(	_
68-68	12747-12750	MRC	_
68-69	12751-12760	Cognition	_
68-70	12761-12764	and	_
68-71	12765-12770	Brain	_
68-72	12771-12779	Sciences	_
68-73	12780-12784	Unit	_
68-74	12785-12786	,	_
68-75	12787-12796	Cambridge	_
68-76	12797-12798	,	_
68-77	12799-12801	UK	_
68-78	12802-12803	;	_
68-79	12804-12808	http	_
68-80	12809-12810	:	_
68-81	12811-12836	//marsbar.sourceforge.net	_
68-82	12837-12838	)	_
68-83	12839-12840	.	_

Text=Registration and analysis of EEG data We used a Brain Amp MR-compatible amplifier (Brain Products, Gilching, Germany) to simultaneously record the EEG and fMRI according to previously reported procedures.
69-1	12841-12853	Registration	_
69-2	12854-12857	and	_
69-3	12858-12866	analysis	_
69-4	12867-12869	of	_
69-5	12870-12873	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
69-6	12874-12878	data	_
69-7	12879-12881	We	_
69-8	12882-12886	used	_
69-9	12887-12888	a	_
69-10	12889-12894	Brain	_
69-11	12895-12898	Amp	_
69-12	12899-12912	MR-compatible	_
69-13	12913-12922	amplifier	_
69-14	12923-12924	(	_
69-15	12925-12930	Brain	_
69-16	12931-12939	Products	_
69-17	12940-12941	,	_
69-18	12942-12950	Gilching	_
69-19	12951-12952	,	_
69-20	12953-12960	Germany	_
69-21	12961-12962	)	_
69-22	12963-12965	to	_
69-23	12966-12980	simultaneously	_
69-24	12981-12987	record	_
69-25	12988-12991	the	_
69-26	12992-12995	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
69-27	12996-12999	and	_
69-28	13000-13004	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
69-29	13005-13014	according	_
69-30	13015-13017	to	_
69-31	13018-13028	previously	_
69-32	13029-13037	reported	_
69-33	13038-13048	procedures	_
69-34	13049-13050	.	_

Text=We used a 32-channel EEG cap (Easycap BrainCap-MR 3–0 32Ch) with 30 sintered Ag/Ag Cl ring electrodes placed in accordance with the international 10–10 system.
70-1	13051-13053	We	_
70-2	13054-13058	used	_
70-3	13059-13060	a	_
70-4	13061-13071	32-channel	_
70-5	13072-13075	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
70-6	13076-13079	cap	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
70-7	13080-13081	(	_
70-8	13082-13089	Easycap	_
70-9	13090-13101	BrainCap-MR	_
70-10	13102-13105	3–0	_
70-11	13106-13110	32Ch	_
70-12	13111-13112	)	_
70-13	13113-13117	with	_
70-14	13118-13120	30	_
70-15	13121-13129	sintered	_
70-16	13130-13135	Ag/Ag	_
70-17	13136-13138	Cl	_
70-18	13139-13143	ring	_
70-19	13144-13154	electrodes	_
70-20	13155-13161	placed	_
70-21	13162-13164	in	_
70-22	13165-13175	accordance	_
70-23	13176-13180	with	_
70-24	13181-13184	the	_
70-25	13185-13198	international	_
70-26	13199-13204	10–10	_
70-27	13205-13211	system	_
70-28	13212-13213	.	_

Text=The FCz site (between Fz and Cz) served as the online reference, maintaining a small distance between the recording reference and the “ active ” electrodes to minimize the risk of amplifier saturation.
71-1	13214-13217	The	_
71-2	13218-13221	FCz	_
71-3	13222-13226	site	_
71-4	13227-13228	(	_
71-5	13229-13236	between	_
71-6	13237-13239	Fz	_
71-7	13240-13243	and	_
71-8	13244-13246	Cz	_
71-9	13247-13248	)	_
71-10	13249-13255	served	_
71-11	13256-13258	as	_
71-12	13259-13262	the	_
71-13	13263-13269	online	_
71-14	13270-13279	reference	_
71-15	13280-13281	,	_
71-16	13282-13293	maintaining	_
71-17	13294-13295	a	_
71-18	13296-13301	small	_
71-19	13302-13310	distance	_
71-20	13311-13318	between	_
71-21	13319-13322	the	_
71-22	13323-13332	recording	_
71-23	13333-13342	reference	_
71-24	13343-13346	and	_
71-25	13347-13350	the	_
71-26	13351-13352	“	_
71-27	13353-13359	active	_
71-28	13360-13361	”	_
71-29	13362-13372	electrodes	_
71-30	13373-13375	to	_
71-31	13376-13384	minimize	_
71-32	13385-13388	the	_
71-33	13389-13393	risk	_
71-34	13394-13396	of	_
71-35	13397-13406	amplifier	_
71-36	13407-13417	saturation	_
71-37	13418-13419	.	_

Text=We placed an electrode on the subject ’ s back to record the electrocardiogram and another under their left eye to record the electrooculogram.
72-1	13420-13422	We	_
72-2	13423-13429	placed	_
72-3	13430-13432	an	_
72-4	13433-13442	electrode	_
72-5	13443-13445	on	_
72-6	13446-13449	the	_
72-7	13450-13457	subject	_
72-8	13458-13459	’	_
72-9	13460-13461	s	_
72-10	13462-13466	back	_
72-11	13467-13469	to	_
72-12	13470-13476	record	_
72-13	13477-13480	the	_
72-14	13481-13498	electrocardiogram	_
72-15	13499-13502	and	_
72-16	13503-13510	another	_
72-17	13511-13516	under	_
72-18	13517-13522	their	_
72-19	13523-13527	left	_
72-20	13528-13531	eye	_
72-21	13532-13534	to	_
72-22	13535-13541	record	_
72-23	13542-13545	the	_
72-24	13546-13562	electrooculogram	_
72-25	13563-13564	.	_

Text=We used custom head coils covered with inner foam padding compatible with the electrodes and cables to decrease head movements by reducing any discomfort or pressure from the electrode cap.
73-1	13565-13567	We	_
73-2	13568-13572	used	_
73-3	13573-13579	custom	_
73-4	13580-13584	head	_
73-5	13585-13590	coils	_
73-6	13591-13598	covered	_
73-7	13599-13603	with	_
73-8	13604-13609	inner	_
73-9	13610-13614	foam	_
73-10	13615-13622	padding	_
73-11	13623-13633	compatible	_
73-12	13634-13638	with	_
73-13	13639-13642	the	_
73-14	13643-13653	electrodes	_
73-15	13654-13657	and	_
73-16	13658-13664	cables	_
73-17	13665-13667	to	_
73-18	13668-13676	decrease	_
73-19	13677-13681	head	_
73-20	13682-13691	movements	_
73-21	13692-13694	by	_
73-22	13695-13703	reducing	_
73-23	13704-13707	any	_
73-24	13708-13718	discomfort	_
73-25	13719-13721	or	_
73-26	13722-13730	pressure	_
73-27	13731-13735	from	_
73-28	13736-13739	the	_
73-29	13740-13749	electrode	_
73-30	13750-13753	cap	_
73-31	13754-13755	.	_

Text=We maintained an impedance of <5 kΩ between the electrode and scalp during EEG recording.
74-1	13756-13758	We	_
74-2	13759-13769	maintained	_
74-3	13770-13772	an	_
74-4	13773-13782	impedance	_
74-5	13783-13785	of	_
74-6	13786-13787	<	_
74-7	13788-13789	5	_
74-8	13790-13792	kΩ	_
74-9	13793-13800	between	_
74-10	13801-13804	the	_
74-11	13805-13814	electrode	_
74-12	13815-13818	and	_
74-13	13819-13824	scalp	_
74-14	13825-13831	during	_
74-15	13832-13835	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
74-16	13836-13845	recording	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
74-17	13846-13847	.	_

Text=Data were acquired at a 5000 Hz sampling rate (16 bit, 0.5 mV resolution, 16.38 mV dynamic range) with an online bandpass filter of 0.016–250 Hz.
75-1	13848-13852	Data	_
75-2	13853-13857	were	_
75-3	13858-13866	acquired	_
75-4	13867-13869	at	_
75-5	13870-13871	a	_
75-6	13872-13876	5000	_
75-7	13877-13879	Hz	_
75-8	13880-13888	sampling	_
75-9	13889-13893	rate	_
75-10	13894-13895	(	_
75-11	13896-13898	16	_
75-12	13899-13902	bit	_
75-13	13903-13904	,	_
75-14	13905-13908	0.5	_
75-15	13909-13911	mV	_
75-16	13912-13922	resolution	_
75-17	13923-13924	,	_
75-18	13925-13930	16.38	_
75-19	13931-13933	mV	_
75-20	13934-13941	dynamic	_
75-21	13942-13947	range	_
75-22	13948-13949	)	_
75-23	13950-13954	with	_
75-24	13955-13957	an	_
75-25	13958-13964	online	_
75-26	13965-13973	bandpass	_
75-27	13974-13980	filter	_
75-28	13981-13983	of	_
75-29	13984-13993	0.016–250	_
75-30	13994-13996	Hz	_
75-31	13997-13998	.	_

Text=EEG artifact correction and validation We subtracted averaged artifacts using Brain Vision Analyzer software algorithms (BrainProducts, Gilching, Germany) to correct the EEG data for MR gradient and ballistocardiac artifacts as described previously.
76-1	13999-14002	EEG	_
76-2	14003-14011	artifact	_
76-3	14012-14022	correction	_
76-4	14023-14026	and	_
76-5	14027-14037	validation	_
76-6	14038-14040	We	_
76-7	14041-14051	subtracted	_
76-8	14052-14060	averaged	_
76-9	14061-14070	artifacts	_
76-10	14071-14076	using	_
76-11	14077-14082	Brain	_
76-12	14083-14089	Vision	_
76-13	14090-14098	Analyzer	_
76-14	14099-14107	software	_
76-15	14108-14118	algorithms	_
76-16	14119-14120	(	_
76-17	14121-14134	BrainProducts	_
76-18	14135-14136	,	_
76-19	14137-14145	Gilching	_
76-20	14146-14147	,	_
76-21	14148-14155	Germany	_
76-22	14156-14157	)	_
76-23	14158-14160	to	_
76-24	14161-14168	correct	_
76-25	14169-14172	the	_
76-26	14173-14176	EEG	_
76-27	14177-14181	data	_
76-28	14182-14185	for	_
76-29	14186-14188	MR	_
76-30	14189-14197	gradient	_
76-31	14198-14201	and	_
76-32	14202-14217	ballistocardiac	_
76-33	14218-14227	artifacts	_
76-34	14228-14230	as	_
76-35	14231-14240	described	_
76-36	14241-14251	previously	_
76-37	14252-14253	.	_

Text=The EEG data were processed using a bandpass filter of 0.53–70 Hz, down-sampled to 250 Hz, and re-referenced to a common average.
77-1	14254-14257	The	_
77-2	14258-14261	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
77-3	14262-14266	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
77-4	14267-14271	were	_
77-5	14272-14281	processed	_
77-6	14282-14287	using	_
77-7	14288-14289	a	_
77-8	14290-14298	bandpass	_
77-9	14299-14305	filter	_
77-10	14306-14308	of	_
77-11	14309-14316	0.53–70	_
77-12	14317-14319	Hz	_
77-13	14320-14321	,	_
77-14	14322-14334	down-sampled	_
77-15	14335-14337	to	_
77-16	14338-14341	250	_
77-17	14342-14344	Hz	_
77-18	14345-14346	,	_
77-19	14347-14350	and	_
77-20	14351-14364	re-referenced	_
77-21	14365-14367	to	_
77-22	14368-14369	a	_
77-23	14370-14376	common	_
77-24	14377-14384	average	_
77-25	14385-14386	.	_

Text=We applied additional artifact correction based on independent component analysis (ICA) to exclude repetitive uniform artifacts, such as line noise and eye blinks.
78-1	14387-14389	We	_
78-2	14390-14397	applied	_
78-3	14398-14408	additional	_
78-4	14409-14417	artifact	_
78-5	14418-14428	correction	_
78-6	14429-14434	based	_
78-7	14435-14437	on	_
78-8	14438-14449	independent	_
78-9	14450-14459	component	_
78-10	14460-14468	analysis	_
78-11	14469-14470	(	_
78-12	14471-14474	ICA	_
78-13	14475-14476	)	_
78-14	14477-14479	to	_
78-15	14480-14487	exclude	_
78-16	14488-14498	repetitive	_
78-17	14499-14506	uniform	_
78-18	14507-14516	artifacts	_
78-19	14517-14518	,	_
78-20	14519-14523	such	_
78-21	14524-14526	as	_
78-22	14527-14531	line	_
78-23	14532-14537	noise	_
78-24	14538-14541	and	_
78-25	14542-14545	eye	_
78-26	14546-14552	blinks	_
78-27	14553-14554	.	_

Text=All independent components that appeared to correspond to horizontal eye movements, blinks, or components potentially assignable to ballistocardiac and residual gradient artifacts were visually inspected and excluded.
79-1	14555-14558	All	_
79-2	14559-14570	independent	_
79-3	14571-14581	components	_
79-4	14582-14586	that	_
79-5	14587-14595	appeared	_
79-6	14596-14598	to	_
79-7	14599-14609	correspond	_
79-8	14610-14612	to	_
79-9	14613-14623	horizontal	_
79-10	14624-14627	eye	_
79-11	14628-14637	movements	_
79-12	14638-14639	,	_
79-13	14640-14646	blinks	_
79-14	14647-14648	,	_
79-15	14649-14651	or	_
79-16	14652-14662	components	_
79-17	14663-14674	potentially	_
79-18	14675-14685	assignable	_
79-19	14686-14688	to	_
79-20	14689-14704	ballistocardiac	_
79-21	14705-14708	and	_
79-22	14709-14717	residual	_
79-23	14718-14726	gradient	_
79-24	14727-14736	artifacts	_
79-25	14737-14741	were	_
79-26	14742-14750	visually	_
79-27	14751-14760	inspected	_
79-28	14761-14764	and	_
79-29	14765-14773	excluded	_
79-30	14774-14775	.	_

Text=We then performed back-projection of the remaining independent components to restore the EEG data to the original voltage and time scales.
80-1	14776-14778	We	_
80-2	14779-14783	then	_
80-3	14784-14793	performed	_
80-4	14794-14809	back-projection	_
80-5	14810-14812	of	_
80-6	14813-14816	the	_
80-7	14817-14826	remaining	_
80-8	14827-14838	independent	_
80-9	14839-14849	components	_
80-10	14850-14852	to	_
80-11	14853-14860	restore	_
80-12	14861-14864	the	_
80-13	14865-14868	EEG	_
80-14	14869-14873	data	_
80-15	14874-14876	to	_
80-16	14877-14880	the	_
80-17	14881-14889	original	_
80-18	14890-14897	voltage	_
80-19	14898-14901	and	_
80-20	14902-14906	time	_
80-21	14907-14913	scales	_
80-22	14914-14915	.	_

Text=Finally, we rejected any intervals that included amplitudes> 70 mV.
81-1	14916-14923	Finally	_
81-2	14924-14925	,	_
81-3	14926-14928	we	_
81-4	14929-14937	rejected	_
81-5	14938-14941	any	_
81-6	14942-14951	intervals	_
81-7	14952-14956	that	_
81-8	14957-14965	included	_
81-9	14966-14976	amplitudes	_
81-10	14977-14978	>	_
81-11	14979-14981	70	_
81-12	14982-14984	mV	_
81-13	14985-14986	.	_

Text=ERP analysis EEG epochs (100 ms pre-stimulus, 412 ms post-stimulus) associated with each stimulus type were excised from the continuous record at the conclusion of the experiment.
82-1	14987-14990	ERP	_
82-2	14991-14999	analysis	_
82-3	15000-15003	EEG	_
82-4	15004-15010	epochs	_
82-5	15011-15012	(	_
82-6	15013-15016	100	_
82-7	15017-15019	ms	_
82-8	15020-15032	pre-stimulus	_
82-9	15033-15034	,	_
82-10	15035-15038	412	_
82-11	15039-15041	ms	_
82-12	15042-15055	post-stimulus	_
82-13	15056-15057	)	_
82-14	15058-15068	associated	_
82-15	15069-15073	with	_
82-16	15074-15078	each	_
82-17	15079-15087	stimulus	_
82-18	15088-15092	type	_
82-19	15093-15097	were	_
82-20	15098-15105	excised	_
82-21	15106-15110	from	_
82-22	15111-15114	the	_
82-23	15115-15125	continuous	_
82-24	15126-15132	record	_
82-25	15133-15135	at	_
82-26	15136-15139	the	_
82-27	15140-15150	conclusion	_
82-28	15151-15153	of	_
82-29	15154-15157	the	_
82-30	15158-15168	experiment	_
82-31	15169-15170	.	_

Text=All single-trial epochs were pre-stimulus baseline-corrected, and artifact-free epochs were segregated by stimulus codes (omission or baseline tone) and averaged for each subject.
83-1	15171-15174	All	_
83-2	15175-15187	single-trial	_
83-3	15188-15194	epochs	_
83-4	15195-15199	were	_
83-5	15200-15212	pre-stimulus	_
83-6	15213-15231	baseline-corrected	_
83-7	15232-15233	,	_
83-8	15234-15237	and	_
83-9	15238-15251	artifact-free	_
83-10	15252-15258	epochs	_
83-11	15259-15263	were	_
83-12	15264-15274	segregated	_
83-13	15275-15277	by	_
83-14	15278-15286	stimulus	_
83-15	15287-15292	codes	_
83-16	15293-15294	(	_
83-17	15295-15303	omission	_
83-18	15304-15306	or	_
83-19	15307-15315	baseline	_
83-20	15316-15320	tone	_
83-21	15321-15322	)	_
83-22	15323-15326	and	_
83-23	15327-15335	averaged	_
83-24	15336-15339	for	_
83-25	15340-15344	each	_
83-26	15345-15352	subject	_
83-27	15353-15354	.	_

Text=No significant difference was found in the number of accepted epochs between the conditions, and a group average was calculated across all subjects of each group.
84-1	15355-15357	No	_
84-2	15358-15369	significant	_
84-3	15370-15380	difference	_
84-4	15381-15384	was	_
84-5	15385-15390	found	_
84-6	15391-15393	in	_
84-7	15394-15397	the	_
84-8	15398-15404	number	_
84-9	15405-15407	of	_
84-10	15408-15416	accepted	_
84-11	15417-15423	epochs	_
84-12	15424-15431	between	_
84-13	15432-15435	the	_
84-14	15436-15446	conditions	_
84-15	15447-15448	,	_
84-16	15449-15452	and	_
84-17	15453-15454	a	_
84-18	15455-15460	group	_
84-19	15461-15468	average	_
84-20	15469-15472	was	_
84-21	15473-15483	calculated	_
84-22	15484-15490	across	_
84-23	15491-15494	all	_
84-24	15495-15503	subjects	_
84-25	15504-15506	of	_
84-26	15507-15511	each	_
84-27	15512-15517	group	_
84-28	15518-15519	.	_

Text=Difference waveforms were constructed by subtracting the tone-associated waveforms from the omission-associated waveforms.
85-1	15520-15530	Difference	_
85-2	15531-15540	waveforms	_
85-3	15541-15545	were	_
85-4	15546-15557	constructed	_
85-5	15558-15560	by	_
85-6	15561-15572	subtracting	_
85-7	15573-15576	the	_
85-8	15577-15592	tone-associated	_
85-9	15593-15602	waveforms	_
85-10	15603-15607	from	_
85-11	15608-15611	the	_
85-12	15612-15631	omission-associated	_
85-13	15632-15641	waveforms	_
85-14	15642-15643	.	_

Text=Topographic distributions were inspected to verify that the maximum MMN was observed at the Fz or Cz electrodes, where the MMN is typically greatest.
86-1	15644-15655	Topographic	_
86-2	15656-15669	distributions	_
86-3	15670-15674	were	_
86-4	15675-15684	inspected	_
86-5	15685-15687	to	_
86-6	15688-15694	verify	_
86-7	15695-15699	that	_
86-8	15700-15703	the	_
86-9	15704-15711	maximum	_
86-10	15712-15715	MMN	_
86-11	15716-15719	was	_
86-12	15720-15728	observed	_
86-13	15729-15731	at	_
86-14	15732-15735	the	_
86-15	15736-15738	Fz	_
86-16	15739-15741	or	_
86-17	15742-15744	Cz	_
86-18	15745-15755	electrodes	_
86-19	15756-15757	,	_
86-20	15758-15763	where	_
86-21	15764-15767	the	_
86-22	15768-15771	MMN	_
86-23	15772-15774	is	_
86-24	15775-15784	typically	_
86-25	15785-15793	greatest	_
86-26	15794-15795	.	_

Text=Peak MMN amplitudes were detected within latency ranges of 120–185 ms.
87-1	15796-15800	Peak	_
87-2	15801-15804	MMN	_
87-3	15805-15815	amplitudes	_
87-4	15816-15820	were	_
87-5	15821-15829	detected	_
87-6	15830-15836	within	_
87-7	15837-15844	latency	_
87-8	15845-15851	ranges	_
87-9	15852-15854	of	_
87-10	15855-15862	120–185	_
87-11	15863-15865	ms	_
87-12	15866-15867	.	_

Text=Analyses were restricted to MMN amplitudes and latencies at Fz and Cz for the purposes of this study, and the MMN amplitudes were measured relative to the pre-stimulus baseline.
88-1	15868-15876	Analyses	_
88-2	15877-15881	were	_
88-3	15882-15892	restricted	_
88-4	15893-15895	to	_
88-5	15896-15899	MMN	_
88-6	15900-15910	amplitudes	_
88-7	15911-15914	and	_
88-8	15915-15924	latencies	_
88-9	15925-15927	at	_
88-10	15928-15930	Fz	_
88-11	15931-15934	and	_
88-12	15935-15937	Cz	_
88-13	15938-15941	for	_
88-14	15942-15945	the	_
88-15	15946-15954	purposes	_
88-16	15955-15957	of	_
88-17	15958-15962	this	_
88-18	15963-15968	study	_
88-19	15969-15970	,	_
88-20	15971-15974	and	_
88-21	15975-15978	the	_
88-22	15979-15982	MMN	_
88-23	15983-15993	amplitudes	_
88-24	15994-15998	were	_
88-25	15999-16007	measured	_
88-26	16008-16016	relative	_
88-27	16017-16019	to	_
88-28	16020-16023	the	_
88-29	16024-16036	pre-stimulus	_
88-30	16037-16045	baseline	_
88-31	16046-16047	.	_

Text=Image acquisition for DTI All MRI scans for DTI were obtained following image acquisition for fMRI as described previously.
89-1	16048-16053	Image	_
89-2	16054-16065	acquisition	_
89-3	16066-16069	for	_
89-4	16070-16073	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
89-5	16074-16077	All	_
89-6	16078-16081	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
89-7	16082-16087	scans	_
89-8	16088-16091	for	_
89-9	16092-16095	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
89-10	16096-16100	were	_
89-11	16101-16109	obtained	_
89-12	16110-16119	following	_
89-13	16120-16125	image	_
89-14	16126-16137	acquisition	_
89-15	16138-16141	for	_
89-16	16142-16146	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
89-17	16147-16149	as	_
89-18	16150-16159	described	_
89-19	16160-16170	previously	_
89-20	16171-16172	.	_

Text=Regular structural images, such as T1-weighted spin-echo images, T2-weighted turbo spin-echo images, and fluid-attenuated inversion recovery images, were obtained before the acquisition of diffusion tensor images.
90-1	16173-16180	Regular	_
90-2	16181-16191	structural	_
90-3	16192-16198	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
90-4	16199-16200	,	_
90-5	16201-16205	such	_
90-6	16206-16208	as	_
90-7	16209-16220	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
90-8	16221-16230	spin-echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
90-9	16231-16237	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
90-10	16238-16239	,	_
90-11	16240-16251	T2-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
90-12	16252-16257	turbo	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
90-13	16258-16267	spin-echo	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
90-14	16268-16274	images	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
90-15	16275-16276	,	_
90-16	16277-16280	and	_
90-17	16281-16297	fluid-attenuated	_
90-18	16298-16307	inversion	_
90-19	16308-16316	recovery	_
90-20	16317-16323	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
90-21	16324-16325	,	_
90-22	16326-16330	were	_
90-23	16331-16339	obtained	_
90-24	16340-16346	before	_
90-25	16347-16350	the	_
90-26	16351-16362	acquisition	_
90-27	16363-16365	of	_
90-28	16366-16375	diffusion	_
90-29	16376-16382	tensor	_
90-30	16383-16389	images	_
90-31	16390-16391	.	_

Text=DTI was performed utilizing the spin-echo echo-planar technique with the following parameters: echo time = 70 ms, repetition time = 5452 ms, voxel size = 1.75 × 1.75 × 3 mm, number of averages = 2, and contiguous axial slices = 50.
91-1	16392-16395	DTI	_
91-2	16396-16399	was	_
91-3	16400-16409	performed	_
91-4	16410-16419	utilizing	_
91-5	16420-16423	the	_
91-6	16424-16433	spin-echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
91-7	16434-16445	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
91-8	16446-16455	technique	_
91-9	16456-16460	with	_
91-10	16461-16464	the	_
91-11	16465-16474	following	_
91-12	16475-16485	parameters	_
91-13	16486-16487	:	_
91-14	16488-16492	echo	_
91-15	16493-16497	time	_
91-16	16498-16499	=	_
91-17	16500-16502	70	_
91-18	16503-16505	ms	_
91-19	16506-16507	,	_
91-20	16508-16518	repetition	_
91-21	16519-16523	time	_
91-22	16524-16525	=	_
91-23	16526-16530	5452	_
91-24	16531-16533	ms	_
91-25	16534-16535	,	_
91-26	16536-16541	voxel	_
91-27	16542-16546	size	_
91-28	16547-16548	=	_
91-29	16549-16553	1.75	_
91-30	16554-16555	×	_
91-31	16556-16560	1.75	_
91-32	16561-16562	×	_
91-33	16563-16564	3	_
91-34	16565-16567	mm	_
91-35	16568-16569	,	_
91-36	16570-16576	number	_
91-37	16577-16579	of	_
91-38	16580-16588	averages	_
91-39	16589-16590	=	_
91-40	16591-16592	2	_
91-41	16593-16594	,	_
91-42	16595-16598	and	_
91-43	16599-16609	contiguous	_
91-44	16610-16615	axial	_
91-45	16616-16622	slices	_
91-46	16623-16624	=	_
91-47	16625-16627	50	_
91-48	16628-16629	.	_

Text=Images were obtained with 32-direction diffusion encoding (b = 1000 s/mm2 for each direction) and no diffusion encoding (b = 0 s/mm2).
92-1	16630-16636	Images	_
92-2	16637-16641	were	_
92-3	16642-16650	obtained	_
92-4	16651-16655	with	_
92-5	16656-16668	32-direction	_
92-6	16669-16678	diffusion	_
92-7	16679-16687	encoding	_
92-8	16688-16689	(	_
92-9	16690-16691	b	_
92-10	16692-16693	=	_
92-11	16694-16698	1000	_
92-12	16699-16704	s/mm2	_
92-13	16705-16708	for	_
92-14	16709-16713	each	_
92-15	16714-16723	direction	_
92-16	16724-16725	)	_
92-17	16726-16729	and	_
92-18	16730-16732	no	_
92-19	16733-16742	diffusion	_
92-20	16743-16751	encoding	_
92-21	16752-16753	(	_
92-22	16754-16755	b	_
92-23	16756-16757	=	_
92-24	16758-16759	0	_
92-25	16760-16765	s/mm2	_
92-26	16766-16767	)	_
92-27	16768-16769	.	_

Text=The scan time was 7 min 17 s. DTI analysis Tract-based spatial statistics As described in detail previously, we first carried out voxel-wise statistical analysis as an exploratory analysis using tract-based spatial statistics (TBSS) (S2 Fig), which is available as part of the FMRIB software library (FSL).
93-1	16770-16773	The	_
93-2	16774-16778	scan	_
93-3	16779-16783	time	_
93-4	16784-16787	was	_
93-5	16788-16789	7	_
93-6	16790-16793	min	_
93-7	16794-16796	17	_
93-8	16797-16799	s.	_
93-9	16800-16803	DTI	_
93-10	16804-16812	analysis	_
93-11	16813-16824	Tract-based	_
93-12	16825-16832	spatial	_
93-13	16833-16843	statistics	_
93-14	16844-16846	As	_
93-15	16847-16856	described	_
93-16	16857-16859	in	_
93-17	16860-16866	detail	_
93-18	16867-16877	previously	_
93-19	16878-16879	,	_
93-20	16880-16882	we	_
93-21	16883-16888	first	_
93-22	16889-16896	carried	_
93-23	16897-16900	out	_
93-24	16901-16911	voxel-wise	_
93-25	16912-16923	statistical	_
93-26	16924-16932	analysis	_
93-27	16933-16935	as	_
93-28	16936-16938	an	_
93-29	16939-16950	exploratory	_
93-30	16951-16959	analysis	_
93-31	16960-16965	using	_
93-32	16966-16977	tract-based	_
93-33	16978-16985	spatial	_
93-34	16986-16996	statistics	_
93-35	16997-16998	(	_
93-36	16999-17003	TBSS	_
93-37	17004-17005	)	_
93-38	17006-17007	(	_
93-39	17008-17010	S2	_
93-40	17011-17014	Fig	_
93-41	17015-17016	)	_
93-42	17017-17018	,	_
93-43	17019-17024	which	_
93-44	17025-17027	is	_
93-45	17028-17037	available	_
93-46	17038-17040	as	_
93-47	17041-17045	part	_
93-48	17046-17048	of	_
93-49	17049-17052	the	_
93-50	17053-17058	FMRIB	_
93-51	17059-17067	software	_
93-52	17068-17075	library	_
93-53	17076-17077	(	_
93-54	17078-17081	FSL	_
93-55	17082-17083	)	_
93-56	17084-17085	.	_

Text=Diffusion tensor images were preprocessed by FSL version 4.2.1, including skull stripping and eddy current correction.
94-1	17086-17095	Diffusion	_
94-2	17096-17102	tensor	_
94-3	17103-17109	images	_
94-4	17110-17114	were	_
94-5	17115-17127	preprocessed	_
94-6	17128-17130	by	_
94-7	17131-17134	FSL	_
94-8	17135-17142	version	_
94-9	17143-17148	4.2.1	_
94-10	17149-17150	,	_
94-11	17151-17160	including	_
94-12	17161-17166	skull	_
94-13	17167-17176	stripping	_
94-14	17177-17180	and	_
94-15	17181-17185	eddy	_
94-16	17186-17193	current	_
94-17	17194-17204	correction	_
94-18	17205-17206	.	_

Text=All subjects ’ fractional anisotropy (FA) data were aligned into a common space by applying the non-linear registration tool FNIRT, which uses a b-spline representation of the registration warp field.
95-1	17207-17210	All	_
95-2	17211-17219	subjects	_
95-3	17220-17221	’	_
95-4	17222-17232	fractional	_
95-5	17233-17243	anisotropy	_
95-6	17244-17245	(	_
95-7	17246-17248	FA	_
95-8	17249-17250	)	_
95-9	17251-17255	data	_
95-10	17256-17260	were	_
95-11	17261-17268	aligned	_
95-12	17269-17273	into	_
95-13	17274-17275	a	_
95-14	17276-17282	common	_
95-15	17283-17288	space	_
95-16	17289-17291	by	_
95-17	17292-17300	applying	_
95-18	17301-17304	the	_
95-19	17305-17315	non-linear	_
95-20	17316-17328	registration	_
95-21	17329-17333	tool	_
95-22	17334-17339	FNIRT	_
95-23	17340-17341	,	_
95-24	17342-17347	which	_
95-25	17348-17352	uses	_
95-26	17353-17354	a	_
95-27	17355-17363	b-spline	_
95-28	17364-17378	representation	_
95-29	17379-17381	of	_
95-30	17382-17385	the	_
95-31	17386-17398	registration	_
95-32	17399-17403	warp	_
95-33	17404-17409	field	_
95-34	17410-17411	.	_

Text=A mean FA image was provided and thinned to create a mean FA skeleton representing the centers of all tracts common to the group.
96-1	17412-17413	A	_
96-2	17414-17418	mean	_
96-3	17419-17421	FA	_
96-4	17422-17427	image	_
96-5	17428-17431	was	_
96-6	17432-17440	provided	_
96-7	17441-17444	and	_
96-8	17445-17452	thinned	_
96-9	17453-17455	to	_
96-10	17456-17462	create	_
96-11	17463-17464	a	_
96-12	17465-17469	mean	_
96-13	17470-17472	FA	_
96-14	17473-17481	skeleton	_
96-15	17482-17494	representing	_
96-16	17495-17498	the	_
96-17	17499-17506	centers	_
96-18	17507-17509	of	_
96-19	17510-17513	all	_
96-20	17514-17520	tracts	_
96-21	17521-17527	common	_
96-22	17528-17530	to	_
96-23	17531-17534	the	_
96-24	17535-17540	group	_
96-25	17541-17542	.	_

Text=Group comparisons were performed with Randomise version 2.1 from FSL, and both control vs. patient and patient vs. control contrasts were tested with 5000 permutations.
97-1	17543-17548	Group	_
97-2	17549-17560	comparisons	_
97-3	17561-17565	were	_
97-4	17566-17575	performed	_
97-5	17576-17580	with	_
97-6	17581-17590	Randomise	_
97-7	17591-17598	version	_
97-8	17599-17602	2.1	_
97-9	17603-17607	from	_
97-10	17608-17611	FSL	_
97-11	17612-17613	,	_
97-12	17614-17617	and	_
97-13	17618-17622	both	_
97-14	17623-17630	control	_
97-15	17631-17634	vs.	_
97-16	17635-17642	patient	_
97-17	17643-17646	and	_
97-18	17647-17654	patient	_
97-19	17655-17658	vs.	_
97-20	17659-17666	control	_
97-21	17667-17676	contrasts	_
97-22	17677-17681	were	_
97-23	17682-17688	tested	_
97-24	17689-17693	with	_
97-25	17694-17698	5000	_
97-26	17699-17711	permutations	_
97-27	17712-17713	.	_

Text=We used threshold-free cluster enhancement as implemented within Randomise, which provides the ability to perform cluster-based inferences without setting an arbitrary cluster-forming threshold.
98-1	17714-17716	We	_
98-2	17717-17721	used	_
98-3	17722-17736	threshold-free	_
98-4	17737-17744	cluster	_
98-5	17745-17756	enhancement	_
98-6	17757-17759	as	_
98-7	17760-17771	implemented	_
98-8	17772-17778	within	_
98-9	17779-17788	Randomise	_
98-10	17789-17790	,	_
98-11	17791-17796	which	_
98-12	17797-17805	provides	_
98-13	17806-17809	the	_
98-14	17810-17817	ability	_
98-15	17818-17820	to	_
98-16	17821-17828	perform	_
98-17	17829-17842	cluster-based	_
98-18	17843-17853	inferences	_
98-19	17854-17861	without	_
98-20	17862-17869	setting	_
98-21	17870-17872	an	_
98-22	17873-17882	arbitrary	_
98-23	17883-17898	cluster-forming	_
98-24	17899-17908	threshold	_
98-25	17909-17910	.	_

Text=Voxel-wise statistical inferences were made on the resulting statistic image, and the significance was set to p <0.05 with correction for FWE.
99-1	17911-17921	Voxel-wise	_
99-2	17922-17933	statistical	_
99-3	17934-17944	inferences	_
99-4	17945-17949	were	_
99-5	17950-17954	made	_
99-6	17955-17957	on	_
99-7	17958-17961	the	_
99-8	17962-17971	resulting	_
99-9	17972-17981	statistic	_
99-10	17982-17987	image	_
99-11	17988-17989	,	_
99-12	17990-17993	and	_
99-13	17994-17997	the	_
99-14	17998-18010	significance	_
99-15	18011-18014	was	_
99-16	18015-18018	set	_
99-17	18019-18021	to	_
99-18	18022-18023	p	_
99-19	18024-18025	<	_
99-20	18026-18030	0.05	_
99-21	18031-18035	with	_
99-22	18036-18046	correction	_
99-23	18047-18050	for	_
99-24	18051-18054	FWE	_
99-25	18055-18056	.	_

Text=Tract-specific analysis As our specific interest was the ACC, we performed tract-specific analysis of the 3D diffusion tensor tractograph using dTV II and VOLUME-ONE software (free software from Masutani, http: //www.medimg.info.hiroshima-cu.ac.jp/dTV.IISR/dTV.htm) on a Windows PC workstation as described previously.
100-1	18057-18071	Tract-specific	_
100-2	18072-18080	analysis	_
100-3	18081-18083	As	_
100-4	18084-18087	our	_
100-5	18088-18096	specific	_
100-6	18097-18105	interest	_
100-7	18106-18109	was	_
100-8	18110-18113	the	_
100-9	18114-18117	ACC	_
100-10	18118-18119	,	_
100-11	18120-18122	we	_
100-12	18123-18132	performed	_
100-13	18133-18147	tract-specific	_
100-14	18148-18156	analysis	_
100-15	18157-18159	of	_
100-16	18160-18163	the	_
100-17	18164-18166	3D	_
100-18	18167-18176	diffusion	_
100-19	18177-18183	tensor	_
100-20	18184-18195	tractograph	_
100-21	18196-18201	using	_
100-22	18202-18205	dTV	_
100-23	18206-18208	II	_
100-24	18209-18212	and	_
100-25	18213-18223	VOLUME-ONE	_
100-26	18224-18232	software	_
100-27	18233-18234	(	_
100-28	18235-18239	free	_
100-29	18240-18248	software	_
100-30	18249-18253	from	_
100-31	18254-18262	Masutani	_
100-32	18263-18264	,	_
100-33	18265-18269	http	_
100-34	18270-18271	:	_
100-35	18272-18325	//www.medimg.info.hiroshima-cu.ac.jp/dTV.IISR/dTV.htm	_
100-36	18326-18327	)	_
100-37	18328-18330	on	_
100-38	18331-18332	a	_
100-39	18333-18340	Windows	_
100-40	18341-18343	PC	_
100-41	18344-18355	workstation	_
100-42	18356-18358	as	_
100-43	18359-18368	described	_
100-44	18369-18379	previously	_
100-45	18380-18381	.	_

Text=Two ROIs were used to extract the cingulum bundle in accordance with the two-ROI method.
101-1	18382-18385	Two	_
101-2	18386-18390	ROIs	_
101-3	18391-18395	were	_
101-4	18396-18400	used	_
101-5	18401-18403	to	_
101-6	18404-18411	extract	_
101-7	18412-18415	the	_
101-8	18416-18424	cingulum	_
101-9	18425-18431	bundle	_
101-10	18432-18434	in	_
101-11	18435-18445	accordance	_
101-12	18446-18450	with	_
101-13	18451-18454	the	_
101-14	18455-18462	two-ROI	_
101-15	18463-18469	method	_
101-16	18470-18471	.	_

Text=The first ROI (‘ seed ’) was chosen on the coronal plane anterior to the pons (S3A Fig).
102-1	18472-18475	The	_
102-2	18476-18481	first	_
102-3	18482-18485	ROI	_
102-4	18486-18487	(	_
102-5	18488-18489	‘	_
102-6	18490-18494	seed	_
102-7	18495-18496	’	_
102-8	18497-18498	)	_
102-9	18499-18502	was	_
102-10	18503-18509	chosen	_
102-11	18510-18512	on	_
102-12	18513-18516	the	_
102-13	18517-18524	coronal	_
102-14	18525-18530	plane	_
102-15	18531-18539	anterior	_
102-16	18540-18542	to	_
102-17	18543-18546	the	_
102-18	18547-18551	pons	_
102-19	18552-18553	(	_
102-20	18554-18557	S3A	_
102-21	18558-18561	Fig	_
102-22	18562-18563	)	_
102-23	18564-18565	.	_

Text=The second ROI (‘ target ’) was placed on a coronal slice posterior to the genu of the corpus callosum (S3B Fig).
103-1	18566-18569	The	_
103-2	18570-18576	second	_
103-3	18577-18580	ROI	_
103-4	18581-18582	(	_
103-5	18583-18584	‘	_
103-6	18585-18591	target	_
103-7	18592-18593	’	_
103-8	18594-18595	)	_
103-9	18596-18599	was	_
103-10	18600-18606	placed	_
103-11	18607-18609	on	_
103-12	18610-18611	a	_
103-13	18612-18619	coronal	_
103-14	18620-18625	slice	_
103-15	18626-18635	posterior	_
103-16	18636-18638	to	_
103-17	18639-18642	the	_
103-18	18643-18647	genu	_
103-19	18648-18650	of	_
103-20	18651-18654	the	_
103-21	18655-18661	corpus	_
103-22	18662-18670	callosum	_
103-23	18671-18672	(	_
103-24	18673-18676	S3B	_
103-25	18677-18680	Fig	_
103-26	18681-18682	)	_
103-27	18683-18684	.	_

Text=The average FA values and mean diffusivity of the AC included in the seed and target (S3D Fig) were calculated separately for each hemisphere after extracting the cingulum bundle (S3C Fig).
104-1	18685-18688	The	_
104-2	18689-18696	average	_
104-3	18697-18699	FA	_
104-4	18700-18706	values	_
104-5	18707-18710	and	_
104-6	18711-18715	mean	_
104-7	18716-18727	diffusivity	_
104-8	18728-18730	of	_
104-9	18731-18734	the	_
104-10	18735-18737	AC	_
104-11	18738-18746	included	_
104-12	18747-18749	in	_
104-13	18750-18753	the	_
104-14	18754-18758	seed	_
104-15	18759-18762	and	_
104-16	18763-18769	target	_
104-17	18770-18771	(	_
104-18	18772-18775	S3D	_
104-19	18776-18779	Fig	_
104-20	18780-18781	)	_
104-21	18782-18786	were	_
104-22	18787-18797	calculated	_
104-23	18798-18808	separately	_
104-24	18809-18812	for	_
104-25	18813-18817	each	_
104-26	18818-18828	hemisphere	_
104-27	18829-18834	after	_
104-28	18835-18845	extracting	_
104-29	18846-18849	the	_
104-30	18850-18858	cingulum	_
104-31	18859-18865	bundle	_
104-32	18866-18867	(	_
104-33	18868-18871	S3C	_
104-34	18872-18875	Fig	_
104-35	18876-18877	)	_
104-36	18878-18879	.	_

Text=Statistical analysis The MMN, ROI, and DTI data were analyzed by analysis of covariance (ANCOVA) with repeated measures using age and education as covariates.
105-1	18880-18891	Statistical	_
105-2	18892-18900	analysis	_
105-3	18901-18904	The	_
105-4	18905-18908	MMN	_
105-5	18909-18910	,	_
105-6	18911-18914	ROI	_
105-7	18915-18916	,	_
105-8	18917-18920	and	_
105-9	18921-18924	DTI	_
105-10	18925-18929	data	_
105-11	18930-18934	were	_
105-12	18935-18943	analyzed	_
105-13	18944-18946	by	_
105-14	18947-18955	analysis	_
105-15	18956-18958	of	_
105-16	18959-18969	covariance	_
105-17	18970-18971	(	_
105-18	18972-18978	ANCOVA	_
105-19	18979-18980	)	_
105-20	18981-18985	with	_
105-21	18986-18994	repeated	_
105-22	18995-19003	measures	_
105-23	19004-19009	using	_
105-24	19010-19013	age	_
105-25	19014-19017	and	_
105-26	19018-19027	education	_
105-27	19028-19030	as	_
105-28	19031-19041	covariates	_
105-29	19042-19043	.	_

Text=Two factors were included for MMN amplitudes and latencies at Fz and Cz: group (patient or control) as a between-subject factor, and electrode (Fz or Cz) as a within-subject factor.
106-1	19044-19047	Two	_
106-2	19048-19055	factors	_
106-3	19056-19060	were	_
106-4	19061-19069	included	_
106-5	19070-19073	for	_
106-6	19074-19077	MMN	_
106-7	19078-19088	amplitudes	_
106-8	19089-19092	and	_
106-9	19093-19102	latencies	_
106-10	19103-19105	at	_
106-11	19106-19108	Fz	_
106-12	19109-19112	and	_
106-13	19113-19115	Cz	_
106-14	19116-19117	:	_
106-15	19118-19123	group	_
106-16	19124-19125	(	_
106-17	19126-19133	patient	_
106-18	19134-19136	or	_
106-19	19137-19144	control	_
106-20	19145-19146	)	_
106-21	19147-19149	as	_
106-22	19150-19151	a	_
106-23	19152-19167	between-subject	_
106-24	19168-19174	factor	_
106-25	19175-19176	,	_
106-26	19177-19180	and	_
106-27	19181-19190	electrode	_
106-28	19191-19192	(	_
106-29	19193-19195	Fz	_
106-30	19196-19198	or	_
106-31	19199-19201	Cz	_
106-32	19202-19203	)	_
106-33	19204-19206	as	_
106-34	19207-19208	a	_
106-35	19209-19223	within-subject	_
106-36	19224-19230	factor	_
106-37	19231-19232	.	_

Text=Three factors were included for changes in t-values in the ROI analysis of the cingulate and temporal cortex: group as a between-subject factor, and laterality (right or left) and location (anterior or middle cingulate; STG, MTG, or HSC) as within-subject factors.
107-1	19233-19238	Three	_
107-2	19239-19246	factors	_
107-3	19247-19251	were	_
107-4	19252-19260	included	_
107-5	19261-19264	for	_
107-6	19265-19272	changes	_
107-7	19273-19275	in	_
107-8	19276-19284	t-values	_
107-9	19285-19287	in	_
107-10	19288-19291	the	_
107-11	19292-19295	ROI	_
107-12	19296-19304	analysis	_
107-13	19305-19307	of	_
107-14	19308-19311	the	_
107-15	19312-19321	cingulate	_
107-16	19322-19325	and	_
107-17	19326-19334	temporal	_
107-18	19335-19341	cortex	_
107-19	19342-19343	:	_
107-20	19344-19349	group	_
107-21	19350-19352	as	_
107-22	19353-19354	a	_
107-23	19355-19370	between-subject	_
107-24	19371-19377	factor	_
107-25	19378-19379	,	_
107-26	19380-19383	and	_
107-27	19384-19394	laterality	_
107-28	19395-19396	(	_
107-29	19397-19402	right	_
107-30	19403-19405	or	_
107-31	19406-19410	left	_
107-32	19411-19412	)	_
107-33	19413-19416	and	_
107-34	19417-19425	location	_
107-35	19426-19427	(	_
107-36	19428-19436	anterior	_
107-37	19437-19439	or	_
107-38	19440-19446	middle	_
107-39	19447-19456	cingulate	_
107-40	19457-19458	;	_
107-41	19459-19462	STG	_
107-42	19463-19464	,	_
107-43	19465-19468	MTG	_
107-44	19469-19470	,	_
107-45	19471-19473	or	_
107-46	19474-19477	HSC	_
107-47	19478-19479	)	_
107-48	19480-19482	as	_
107-49	19483-19497	within-subject	_
107-50	19498-19505	factors	_
107-51	19506-19507	.	_

Text=Two factors were included for DTI FA values: group as a between-subject factor, and laterality (right or left) as a within-subject factor.
108-1	19508-19511	Two	_
108-2	19512-19519	factors	_
108-3	19520-19524	were	_
108-4	19525-19533	included	_
108-5	19534-19537	for	_
108-6	19538-19541	DTI	_
108-7	19542-19544	FA	_
108-8	19545-19551	values	_
108-9	19552-19553	:	_
108-10	19554-19559	group	_
108-11	19560-19562	as	_
108-12	19563-19564	a	_
108-13	19565-19580	between-subject	_
108-14	19581-19587	factor	_
108-15	19588-19589	,	_
108-16	19590-19593	and	_
108-17	19594-19604	laterality	_
108-18	19605-19606	(	_
108-19	19607-19612	right	_
108-20	19613-19615	or	_
108-21	19616-19620	left	_
108-22	19621-19622	)	_
108-23	19623-19625	as	_
108-24	19626-19627	a	_
108-25	19628-19642	within-subject	_
108-26	19643-19649	factor	_
108-27	19650-19651	.	_

Text=Reduced degrees of freedom (Greenhouse-Geisser) were used when appropriate to counter violations of the sphericity assumption underlying ANCOVA with repeated measures (epsilon values were provided).
109-1	19652-19659	Reduced	_
109-2	19660-19667	degrees	_
109-3	19668-19670	of	_
109-4	19671-19678	freedom	_
109-5	19679-19680	(	_
109-6	19681-19699	Greenhouse-Geisser	_
109-7	19700-19701	)	_
109-8	19702-19706	were	_
109-9	19707-19711	used	_
109-10	19712-19716	when	_
109-11	19717-19728	appropriate	_
109-12	19729-19731	to	_
109-13	19732-19739	counter	_
109-14	19740-19750	violations	_
109-15	19751-19753	of	_
109-16	19754-19757	the	_
109-17	19758-19768	sphericity	_
109-18	19769-19779	assumption	_
109-19	19780-19790	underlying	_
109-20	19791-19797	ANCOVA	_
109-21	19798-19802	with	_
109-22	19803-19811	repeated	_
109-23	19812-19820	measures	_
109-24	19821-19822	(	_
109-25	19823-19830	epsilon	_
109-26	19831-19837	values	_
109-27	19838-19842	were	_
109-28	19843-19851	provided	_
109-29	19852-19853	)	_
109-30	19854-19855	.	_

Text=Changes in the BOLD signal analyzed in ROI analysis using MarsBar were correlated with other fMRI and MMN measures by Pearson ’ s correlation, and alpha values of 0.05 were considered significant.
110-1	19856-19863	Changes	_
110-2	19864-19866	in	_
110-3	19867-19870	the	_
110-4	19871-19875	BOLD	_
110-5	19876-19882	signal	_
110-6	19883-19891	analyzed	_
110-7	19892-19894	in	_
110-8	19895-19898	ROI	_
110-9	19899-19907	analysis	_
110-10	19908-19913	using	_
110-11	19914-19921	MarsBar	_
110-12	19922-19926	were	_
110-13	19927-19937	correlated	_
110-14	19938-19942	with	_
110-15	19943-19948	other	_
110-16	19949-19953	fMRI	_
110-17	19954-19957	and	_
110-18	19958-19961	MMN	_
110-19	19962-19970	measures	_
110-20	19971-19973	by	_
110-21	19974-19981	Pearson	_
110-22	19982-19983	’	_
110-23	19984-19985	s	_
110-24	19986-19997	correlation	_
110-25	19998-19999	,	_
110-26	20000-20003	and	_
110-27	20004-20009	alpha	_
110-28	20010-20016	values	_
110-29	20017-20019	of	_
110-30	20020-20024	0.05	_
110-31	20025-20029	were	_
110-32	20030-20040	considered	_
110-33	20041-20052	significant	_
110-34	20053-20054	.	_

Text=PASW Statistics software for Windows version 18.0.0 (SPSS Inc., Chicago, IL, USA) was used for all analyses.
111-1	20055-20059	PASW	_
111-2	20060-20070	Statistics	_
111-3	20071-20079	software	_
111-4	20080-20083	for	_
111-5	20084-20091	Windows	_
111-6	20092-20099	version	_
111-7	20100-20106	18.0.0	_
111-8	20107-20108	(	_
111-9	20109-20113	SPSS	_
111-10	20114-20118	Inc.	_
111-11	20119-20120	,	_
111-12	20121-20128	Chicago	_
111-13	20129-20130	,	_
111-14	20131-20133	IL	_
111-15	20134-20135	,	_
111-16	20136-20139	USA	_
111-17	20140-20141	)	_
111-18	20142-20145	was	_
111-19	20146-20150	used	_
111-20	20151-20154	for	_
111-21	20155-20158	all	_
111-22	20159-20167	analyses	_
111-23	20168-20169	.	_

